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ABSTRACT OF THE DISSERTATION
TAILORING HEME-THIOLATE PROTEINS INTO EFFICIENT BIOCATALYSTS
WITH HIGH SPECIFICITY AND SELECTIVITY
by
Hui Tian
Florida International University, 2010
Miami, Florida
Professor Xiaotang Wang, Major Professor
Cytochrome P450 monooxygenases, one of the most important classes of
heme-thiolate proteins, have attracted considerable interest in the biochemical community
because of its catalytic versatility, substrate diversity and great number in the superfamily.
Although P450s are capable of catalyzing numerous difficult oxidation reactions, the
relatively low stability, low turnover rates and the need of electron-donating cofactors
have limited their practical biotechnological and pharmaceutical applications as isolated
enzymes. The goal of this study is to tailor such heme-thiolate proteins into efficient
biocatalysts with high specificity and selectivity by protein engineering and to better
understand the structure-function relationship in cytochromes P450.
In the effort to engineer P450cam, the prototype member of the P450 superfamily,
into an efficient peroxygenase that utilizes hydrogen peroxide via the “peroxide-shunt”
pathway, site-directed mutagenesis has been used to elucidate the critical roles of

vii

hydrophobic residues in the active site. Various biophysical, biochemical and
spectroscopic techniques have been utilized to investigate the wild-type and mutant
proteins. Three important P450cam variants were obtained showing distinct structural
and functional features. In P450camV247H mutant, which exhibited almost identical
spectral properties with the wild-type, it is demonstrated that a single amino acid switch
turned the monooxygenase into an efficient preoxidase by increasing the peroxidase
activity nearly one thousand folds. In order to tune the distal pocket of P450cam with
polar residues, Leu 246 was replaced with a basic residue, lysine, resulting in a mutant
with spectral features identical to P420, the inactive species of P450. But this
inactive-species-like mutant showed catalytic activities without the facilitation of any
cofactors. By substituting Gly 248 with a histidine, a novel Cys-Fe-His ligation set was
obtained in P450cam which represented the very rare case of His ligation in
heme-thiolate proteins. In addition to serving as a convenient model for hemoprotein
structural studies, the G248H mutant also provided evidence about the nature of the axial
ligand in cytochrome P420 and other engineered hemoproteins with thiolate ligations.
Furthermore, attempts have been made to replace the proximal ligand in sperm whale
myoglobin to construct a heme-thiolate protein model by mimicking the protein
environment of cytochrome P450cam and chloroperoxidase.
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CHAPTER I. LITERATURE REVIEW

1.1 INTRODUCTION OF METALLOPROTEINS
It is an old wisdom that metals are indispensable for life. Nature uses metal ions
extensively for both structural and functional roles. By incorporating metal ions into
proteins,

a

diverse

class

of

biologically

significant

macromolecules

termed

metalloproteins is created. In fact, about one third to one half of all proteins require
metals to carry out their functions (1). Metalloproteins can catalyze some of the most
difficult and yet important transformations in nature, such as photosynthesis, respiration,
electron transfer, water oxidation, molecular oxygen transport and reduction, and
nitrogen fixation (2). The significance of iron, copper, and zinc in biological systems
together with other metals including cobalt, manganese, molybdenum, and nickel has
been evident for decades (3). The catalytic activities of these metal-containing systems
depend on both the nature of the metal and the influence of the protein environment
including the type of ligands provided by the protein, the geometry of the coordination
sphere and the protein structure in the vicinity of the metal ion.
A great deal of effort has been devoted to the understanding of the structure and
function of metalloproteins because of their indispensable roles in biological systems and
their ability to catalyze some of the most difficult chemical reactions under mild and
environmentally friendly conditions. Furthermore, such enzymes are able to catalyze
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regio- and stereo-selective transformations and thus offer products that are critical to the
producrion of fine chemicals, pharmaceuticals, and many other value-added materials. To
better understand the critical roles of metalloproteins, protein engineering has been used
to study their structure-function relationships by either rational design or directed
evolution.
1.1.1 Heme-containing proteins
Heme is comprised of a tetrapyrrole ring system complexed with an iron atom in the
center. One or two axial ligands complete the coordination requirement of the heme iron.
A heme protein (also known as hemoprotein or haemoprotein) contains a heme prosthetic
group, bound either covalently or non-covalently to the protein. As one of the largest
classes of metalloproteins, the heme-containing proteins have attracted a great deal of
attention from the scientific community since the beginning of modern enzymology.
They have diverse biological functions and are able to catalyze a broad spectrum of
biological processes ranging from electron transfer (cytochromes) to oxygen storage
(myoglobin) / transport (hemoglobin) / activation (P450) and molecular sensing (CooA)
(4-6).
Many biochemical and biophysical studies of heme proteins and their variants have
suggested that the type of reaction catalyzed by different hemoproteins is normally
controlled by: 1) the nature of the proximal ligand and its surrounding residues, 2) the
distal environment including conserved significant residues, and 3) the type of heme (7).

2

The most common heme prosthetic group is iron protoporphyrin IX also known as heme
b (Fig. 1.1), which is the prosthetic group found in all the heme proteins discussed in this
dissertation. The ferriprotoporphyrin IX is made up of four pyrrol rings joined by methine
bridges with ferric iron in the center of the molecule replacing the two hydrogen atoms
attached to pyrrol nitrogens. The remaining two axial ligands to the heme iron are located
above (distal) and below (proximal) the porphyrin plane respectively. Different types of
heme have different side chains. There are eight side chains in ferriprotoporphyrin IX
(heme b): four methyl groups at positions 1, 3, 5, and 8, two vinyl groups at positions 2
and 4, and two propionate groups at positions 6 and 7. The carbon atoms of the methine
bridges are symbolized as α, β, γ, and δ (8). In many heme proteins, oxygen or hydrogen
peroxide will bind to the heme iron in the distal site as the proximal site is normally
occupied by certain amino acid heteroatoms. For example, in most heme peroxidases,
there is a histidine nitrogen serving as the proximal ligand; while chloroperoxidase, as an
exception, possesses a cysteinate sulfur ligated to the heme iron. The distal side in these
cases is the catalytic center, and its coordination state varies in different states of the
enzyme during catalytic cycles. In some other heme proteins with no directly bound
oxygen or hydrogen peroxide, both of the axial coordination sites are occupied by
heteroatoms from the nearby amino acids, like cytochrome c which has a histidine and
methionine as the axial ligands (9).

3

2

3


1

4
N



N



Fe
N

8

N

5


7

6

COO-

COO-

Figure 1.1 Structure of iron protoporphyrin IX, heme b. A-D indicate the location of each pyrrole
ring and α to δ identify the site of each methane bridge.

One of the most important questions about heme proteins is how different heme
proteins achieve such structural and functional diversity by using the same heme
prosthetic group (5-7). For instance, hemoglobin and myoglobin are O2 carriers and can
bind O2 reversibly (10, 11); heme oxygenase (HO) and cytochromes P450 activate O2,
and transfer the oxygen atom to the heme prosthetic group or to other organic molecules
(12-15); FixL protein, CooA protein and guanylate cyclase serve as biological sensors for
O2, CO and NO respectively (16). The protein environment, especially near the active site,
clearly plays an essential role in governing the reactivity of the metal iron, and it could be
the determining factor that controls the functionalities of the distinct hemoproteins with
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essentially identical metal centers. Therefore, the redesign of heme proteins, from one
type into another, not only provides a test of the known factors governing their structure
and function but also allows the direct comparison of two different heme proteins in the
same framework to achieve protein variants with better efficiency and selectivity (7).
1.1.2 Heme-Thiolate Proteins and their structural mimics
Heme-thiolate proteins are a group of heme proteins with a thiolate anion from a
deprotonated cysteine residue serving as the proximal heme ligand (Fig. 1.2 (A)). They
constitute one of the two major categories of heme-containing proteins found in living
organisms. The other group is the heme-imidazole proteins whose axial ligand is an
imidazole group from a hisitidine residue (Fig. 1.2 B). Their difference in the axial ligand
is also indicated in the optical properties of their reduced forms with carbon monoxide
bound: the heme-thiolate proteins usually show a characteristic absorption maximum at
around 450nm, whereas the corresponding absorption spectrum of heme-imidazole
proteins give a Soret peak at around 420nm (17). Therefore, the optical features of CO
complexes have generally been used as a probe for the nature of proximal ligation in
hemoproteins.
There are several classes of heme-thiolate proteins reported such as cytochromes
P450, chloroperoxidase (CPO), nitric oxide synthases (NOS), cystathionine β-synthase,
the sensor protein CooA and eIF2α kinase (17). Heme-thiolate proteins are essentially
among the most versatile biocatalysts of the hemoprotein family. They serve as
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N
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N
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Fe
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OH

HO

O
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O

OH

Figure 1.2 Heme centers of heme-thiolate proteins with Cys as the proximal ligand (A), and
heme-imidazole proteins with His as the proximal ligand (B).

oxidoreductases that perform essential functions in the biological systems. The hallmark
reaction catalyzed by these enzymes is the substrate oxidation, converting R-H to R-OH
(18). It has been suggested that the identity of the axial ligands to the heme iron, the
nature of the heme environment, and the accessibility of the substrate to the active site
combine to play crucial roles in determining the enzyme activities. Because of the
similarity of the protein environment that heme-thiolate proteins and heme-imidazole
proteins share, many studies have been carried out to engineer the heme-imidazole
proteins by replacing the proximal histidine with a cysteine residue to mimic
heme-thiolate proteins, in order to better understand the structure-function relationships
in these heme-containing enzymes.
In fact, the proximal thiolate ligation is not kept intact in various oxidation states in
all heme-thiolate proteins, and in some cases the Fe-thiolate ligation is lost upon
reduction and carbon monoxide binding. That also happens in many hemoproteins with
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engineered iron-thiolate ligands. Table 1.1 listed some examples of the heme-thiolate
proteins and their mimics with redox-dependent axial ligands in various oxidation states.
Table 1.1. Heme-thiolate proteins and their mimics with redox-dependent axial ligand switches.

Protein

Fe (III)

Fe (II)

Fe (II)-CO

Ref

P450

Cys/OH-

Cys

Cys/CO

(13)

CPO

Cys/OH-

Cys

Cys/CO

(19-21)

NOS

Cys/OH-

Cys

Cys/CO

(22, 23)

CooA

Cys/Pro

His/Pro

His/CO

(24, 25)

CBS

Cys/His

Cys/His

His/CO

(26, 27)

Heme-thiolate proteins

Engineered heme-thiolate protein mimics
Mb H93C

Cys

His

His/CO

(28, 29)

CcP H175C/D235L

Cys

Cysteic acid

Cysteic acid/CO

(30)

Cytochrome c M80C

Cys/His

His

His/CO

(9)

Heme oxygenase H25C

Cys/H2O

CO

(31)

NP1 H60C

Cys

H2O

CO

(32)

Cytochrome b5 H39C

Cys/His

His

His/CO

(33)

For instance, in the CO-sensing transcriptional activator CooA, the Cys75 axial
ligand of the ferric heme is exchanged to His77 upon reduction and CO activation.
Therefore, the electronic absorption spectrum of CO-complex of CooA exhibits the Soret
band at around 420nm instead of 450nm, typical of thiolate-ligated hemoproteins (25). In
the listed hemoproteins with engineered heme-thiolate ligations in their ferric forms
(Table 1.1), upon reduction the iron-thiolate ligands are all lost either by oxidation,
dissociation or protonation, resulting in ferrous-CO complexes with 420-nm Soret
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absorption maxima. Heme oxygenase uses His-25 as its proximal iron ligand. The
substitution of His-25 with a cysteine results in a 6-coordinated ligation of the iron to a
cysteinate and water molecule, but the Fe-Cys bond is lost upon being reduced and the
ferrous heme is only loosely bound to a postulated water molecule (31).

1. 2 CYTOCHROMES P450
Cytochrome P450 (CYP) monooxygenase, a red pigment first found in liver
microsomes and named for its spectral properties, is one of the most important
heme-thiolate proteins. The ability of P450s to functionalize unactivated hydrocarbon at
physiological conditions has attracted considerable interests from the chemical and
biological communities (13). There are several books dedicated to the superfamily of
P450 enzymes (14, 34-39). Many reviews have elaborated the chemistry, structure and
functions of P450s (13, 40-44). The P450 enzymes have been identified in all domains of
life and more than 11,500 distinct CYP proteins had been known and named as of Feb.
2009 (45). In all P450s, the heme-thiolate ligation is highly conserved in the proximal
side of the active site and is considered to play critical roles in the catalytic mechanisms.
The cytochromes P450 perform regio- and stereo-specific reactions under physiologial
conditions and the most common reaction catalyzed by cytochrome P450 is a
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monooxygenase reaction in which one atom of oxygen is inserted into an organic
substrate (RH) while the other oxygen atom is reduced to water (Eq. 1).
P450

R-H + NAD(P)H + H+ + O2

R-OH + NAD(P)+ + H2O

(1)

The P450s generally require two electrons from either NADH or NAD(P)H to
activate O2, and the electrons are transferred to the heme of P450 via a protein electron
transport system, usually a reductase and an iron-sulfur protein, depending on the type of
P450s. In addition to hydroxylation, P450s are able to catalyze a number of other
significant reactions as listed in Table 1.2. The catalytic versatility, substrate diversity and
sheer number of P450s have lead to considerable interest over the last few decades in the
engineering of P450 enzymes for a variety of purposes.

Table 1.2 Cytochrome P450-catalyzed reactions (34, 46).

COH

CH

C-H hydroxylation

O

Epoxidation

Allylic Rearrangement
R

R



Desaturation
 X

Reductive Dehalogenation
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Oxidative Dehalogenation

OH

X


Alcohols oxidation

O




 C

C C
O

O

Aldehyde oxidation

 C

C C
H

OH

O

Deformylation

Oxidative deformylation

R1

R2

R3
CHO
R4

R1

R3

R2

R4

HCOOH

O

Sulfoxidation

R

N-Dealkylation

N R

O-Dealkylation

R

N-Oxygenation

S

R'

S

R

R'

N H

O

CH2R'

R'COH

ROH
OH

R

NH2

R

NH2

R



R
O

OH

OR

Peroxidase-type oxidation
R

R1
C

NO Synthase-type oxidation

N OH

R2

R

R

HO

OH

R1
C
R2

10

O

NO (or NxOy)

1.2.1 Catalytic cycle of P450s
The generally accepted catalytic cycle of P450 enzymes is shown in Fig. 1.3 (34).
The resting state (1) is a six-coordinate, low-spin ferric heme, with poryphyrin nitrogen
atoms occupying the four equatorial position and cysteine and water serving as the axial
ligands at the proximal and distal sides, respectively. The catalytic cycle is initiated by
the substrate binding in the protein active site followed by the displacement of the distal
water molecule, converting the six-coordinate low-spin ferric heme to a predominantly
five-coordinate high-spin form (intermediate (2)) (47). In the meantime, the reduction
potential is increased by greater than +100mV (substrate-dependent) upon substrate
binding, which has been shown to initiate electron transfer to the heme from NAD(P)H
via native reductase proteins (48). The first electron transfer leads to the reduction of
ferric to ferrous heme (intermediate (3)), followed by dioxygen binding at the ferrous
heme iron, yielding an unstable ferrous-oxy species (intermediate (4)). The second
electron transfer is suggested to be the rate- limiting step in the cycle followed by
protonation and the formation of the hydroperoxo-iron complex (intermediate (6),
Compound 0). Then this species is further protonated to generate highly reactive
Compound I (49), ferryl-oxo porphyrin π-radical cation, the key intermediate (7) in the
catalysis (Fig. 1.4). This step involves the heterolytic splitting of the oxygen-oxygen
bond and the releasing of a water molecule. A highly conserved threonine residue near
the heme has been suggested to play an essential role to relay protons from the solvent to
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the heme (50, 51). Finally, the Fe-ligated oxygen atom is transferred to the substrate
through intermediate (8) followed by hydroxylation and regeneration of the resting state.

Cpd I

Cpd 0

Figure 1.3 The cytochrome P450 catalytic cycle including the “peroxide-shunt pathway”. RH is
substrate and ROH is the product. The porphyrin molecule is represented as a parallelogram.
Intermediates (6) and (7) are Compound 0 and Compound I respectively.
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Figure 1.4 P450cam putative oxygen complex, Compound I. The heme prosthetic group is
colored in yellow, the substrate is in gray and the bound dioxygen is in red. All other amino acids
are depicted in lines and ribbons. This image was created from the crystal data (PDB code 1DZ9)
using PYMOL (52).

In the standard catalytic cycle, Compound I would hydroxylate the substrate and
regenerate the P450 resting state. Although the main steps mentioned above are similar
for all P450 enzymes, each step is far from being simple and many side reactions exist
leading to the leakage of the cycle (34).
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1.2.2 “Peroxide-shunt” pathway
In the absence of reducing cofactors, partner proteins and dioxygen, P450s are
capable of utilizing hydrogen peroxide or organic peroxy compound as the oxidant to
hydroxylate substrates through the “peroxide-shunt” pathway (Eq. 2) (14):
RH + R’OOH

P450

ROH + R’OH

(2)

As illustrated in Fig. 1.3, the shunt pathway bypasses a large portion of the standard
catalytic cycle by eliminating the rate-limiting electron transfer steps and directly results
in the generation of the FeIII-OOH- complex (Cpd. 0). There are many studies about the
P450 peroxide shunt pathway (53-59). This type of reaction is not suggested to be
physiological, since the turnover rate is quite low and high concentrations of peroxide are
needed to achieve the optimal reaction rate. But on the other hand, some unique P450
enzymes have been reported to function as peroxygenases by utilizing hydrogen peroxide
or the peroxide groups of their subsbtrates as the oxygen donor with high catalytic
turnover rates, compared with a normal monooxygenation reaction or the peroxide-shunt
reaction catalyzed by common P450s (60-66). The “peroxygenase” activity of P450s has
definitely broadened the versatility of the superfamily and offers a possibility to utilize
cell-free P450-dependent catalysis without the requirement of NAD(P)H, and auxiliary
proteins.
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1.2.3 P450 Structure
In the massive superfamily of cytochrome P450s, there are more than 11,500 distinct
CYP proteins known to date, while the sequence identities between the P450 families are
generally low (about 10-30%) (45, 67). Despite the sequence diversities, P450 in many
different families and many different organisms share a high degree of structural
conservation in their secondary and tertiary folds (34, 68, 69). So far, there are over 300
unique P450 structures available in the Protein Data Bank. Most P450 enzymes are
normally described as consisting of α helical and β sheet domains. Unlike peroxidases
which clearly fold into N- and C-terminal helical-rich domains with the heme sandwiched
between the helices from each domain, P450s do not fold into distinctly divided N- and
C-terminal domains. For example, cytochrome P450cam, the first protein to be
crystallized in the P450 superfamily, divides into a helix-rich domain on the right side
and a β-sheet-rich domain on the left side (Fig. 1.5). The heme group is bracketed
between the proximal helix L and distal helix I in the C terminal half of the molecule,
while a majority of the β-structure is also in the C-terminal half but located far from heme
(70, 71).
The heme prosthetic group is deeply embedded in the hydrophobic interior, which
itself provides the largest hydrophobic surface for interactions with the substrates. The
heme is oriented nearly parallel to the surfaces between helices L and I with no
significant exposure to the protein surface (13). The most distinct structural feature of
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P450 is the presence of an unusual proximal ligation, thiolate sulfur provided by a
deprotonated cysteine residue. It has been generally agreed that the Cys thiolate ligand to
the heme iron and its surrounding protein environment play unique and critical roles in
P450 catalysis. In P450s, the protein architecture surrounding the proximal Fe-Cys
ligation is highly conserved. In almost all P450s with known structures, the peptide NH
of the Cys ligand is the proton donor in an H-bond with a peptide carbonyl O atom,
which forms a tight structure placing the Cys sulfur atom in a position surrounded by

β2
β1

B’
G

N-term

A

I

F
E
L
D
C-term

Figure 1.5 Crystal Structure of cytochrome P450cam showing the key elements of secondary
structure in different colors. This figure was generated from the crystal data (PDB code 2CPP)
using PYMOL (70).
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peptide NH groups forming H-bonds with the thiolate ligand (34). For instance in
cytochrome P450cam, the sulfur from Cys357 is surrounded by three amide protons from
Leu358, Gly359 and Gln360, which have been reported to stabilize the coordination of
the anionic thiolate ligand to the reduced heme iron and also control the “push” effect of
the thiolate ligand (70, 72). Other P450 enzymes including P450BM3, P450eryF, and
P450terp also possess such NH-S hydrogen bonds (67, 73, 74). This characteristic feature
has also been found in other heme thiolate enzymes, such as CPO utilizing two of the
three NH-S hydrogen bonds and NOS accepting an additional H-bond from the indole
NH of Trp (20, 75).

1.3. HEME PEROXIDASES
Nonmammalian heme peroxidases and cytochrome P450s are often grouped
together because they both contain a single low-potential ferriprotoporphyrin IX (Fig. 1.1)
and share similar intermediates in their respective catalytic cycles (76). The first heme
peroxidase crystal structure solved was yeast cytochrome c peroxidase (CcP) (77)
followed by the first P450 structure (70). Heme peroxidases have played a key role in the
development of modern enzymology. They are ubiquitous enzymes that catalyze one
electron oxidation of various micro- and macromolecular substrates by utilizing hydrogen
peroxide or lipid hydroperoxides as the oxidant, except for chloroperoxidase which is a
heme-thiolate protein and performs two-electron oxidations as well (8, 78-80). Almost all
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functionally related peroxidases, such as horseradish peroxidase or cytochrome c
peroxidase, possess a histidine proximal ligand. The crystal structure studies of the heme
peroxidases have firmly established the similarity in their active site architecture:
histidine and arginine in the distal side serving as a proton acceptor from hydrogen
peroxide and a charge stabilizer, respectively, and heme-bound histidine and
hydrogen-bonded aspartic acid in the proximal side of the heme prosthetic group (81-85).
1.3.1 Catalytic cycles
Most heme peroxidases follow the reaction scheme as shown in equations (3-5) and
share common reaction intermediates, Compound I and Compound II (8, 86, 87)
Resting state (Fe3+) + H2O2 → Compound I (Fe4+=O, R·) + H2O

(3)

Compound I (Fe4+=O, R·) + SH → Compound II (Fe4+=O) + S·

(4)

Compound II (Fe4+=O) + SH → Resting state (Fe3+) + S·+ H2O

(5)

The catalytic cycle begins with the coordination of one equivalent of hydrogen
peroxide to the resting ferric peroxidase. The bound peroxide undergoes rapid heterolytic
cleavage to produce the active intermediate Cpd I, the ferryl-oxo porphyrin cation radical,
where R is the organic moiety of the heme or an amino acid residue, similar to
cytochrome P450s (88). This is a two-electron oxidation/reduction reaction, in which the
enzyme is oxidized and hydrogen peroxide is reduced to water. In the following steps,
Cpd I is reduced by an organic substrate, usually an aromatic molecule to give a substrate
radical, to the resting state in two sequential one-electron transfer reactions via a second
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active intermediate, Cpd II, a ferryl-oxo porphyrin complex (87, 89). It is different from
P450s which oxidize substrates by inserting one O2-derived oxygen atom into a substrate
C-H bond.
The ability to react rapidly with hydrogen peroxide to form Cpd I has distinguished
peroxidases from other hemoproteins. This characteristic reactivity has a great deal to do
with the influence of the protein environment around the heme center. In most heme
peroxidases, there is a highly conserved hisitidine residue in the distal pocket of the
active site (82-85, 87, 90-93). Many studies have shown that the distal His plays a critical
role as a general acid-base catalyst in the formation of Cpd I in the peroxidase catalytic
cycles (87, 94-97). It is proposed that the conserved His facilitates the generation of the
initial Fe-OOH complex by deprotonating an approaching hydrogen peroxide as a base
and subsequently heterolytically cleaving the O-O bond by protonating the departing
distal oxygen as an acid (Fig .1.6) (98). Also, a network of hydrogen bonds is reported to
assist the distal histidine in its catalytic role in many heme peroxidases such as
horseradish peroxidase (Asn-70 H-bonded to His-42), cytochrome c peroxidase, lignin
peroxidase and Arthromyces rhamosus peroxidase, and others (81, 84, 91, 99).
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Figure 1.6 Mechanism of Compound I formation in heme peoxidases with distal His.

1.3.2 “Push-Pull” mechanism compared with P450s
It is intriguing that heme peroxidases and cytochrome P450 enzymes perform
distinct physiological functions while using the same cofactor. Nevertheless, they do
share the same key, highly reactive intermediate in their catalytic cycles, Cpd I. It has
been reported that the proximal ligand and some distal residues in these heme proteins
play significant roles in the promotion of the hereolytic rupture of the O-O bond of
dioxygen or peroxides and the following formation of Cpd I, but through different
mechanisms because of different structural features. For many heme peroxidases, a
general “push-pull” mechanism has been proposed for this process (Fig. 1.7 (A)) (80, 88,
100). The “push” effect is provided by the proximal histidine ligand whose electron
donor capabilities are enhanced through the H-bonding to a nearby carboxylate group
(e.g., Asp). Meanwhile, the distal histidine accepts a proton from the oxygen atom of
hydrogen peroxide that binds to the heme iron and transfers it to the other oxygen to form
a leaving group. A nearby cationic residue (e.g., protonated Arg) in the distal pocket
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works in concert with the hisitidine to facilitate the O-O bond cleavage. The combination
of the distal histidine and arginine has been suggested to provide the “pull” effect (13).

A

B

Figure 1.7 “Push-pull” mechanisms for O-O bond cleavage of both heme-imidazole protein (A)
and heme-thiolate protein (B), such as horseradish peroxidase and P450 respectively. (13)

However, cytochrome P450 lacks such distal machinery. It possesses a cysteine
proximal ligand, rather than a histidine typical of most peroxidases. This proximal
thiolate ligand has been implicated as a crucial factor to facilitate the heterolytic scission
of the O-O bond through its “push” effect by serving as a strong internal electron donor
(Fig. 1.7 (B)) (13, 80, 101-104). The cysteine thiolate enables the protonation of Cpd 0 by
the facilitation of Asp and Thr that exist in the protein pocket (14). Once the O-O bond is
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heterolytically cleaved, the electron-releasing axial thiolate ligand would help to stabilize
the high-valent nature of Cpd I (13).
1.3.3. Chloroperoxidase: a P450-peroxidase hybrid
Chloroperoxidase is an enzyme discovered by Hager and coworkers about 50 years
ago from the marine fungus Calduriomyces fumugo (105). CPO serves as one of the most
diverse and versatile known heme peroxidases. CPO and cytochromes P450 share a
number of physiochemical properties, but they do have clear functional and structural
differences (106). In addition to its biological role in halogenation of organic molecules,
CPO is also able to use hydrogen peroxide as the oxidant to catalyze one- and
two-electron classical peroxidase reactions and P450- and catalase-type reactions under
acidic conditions. These enzymatic properties have made CPO a very promising
industrial biocatalyst. Cytochrome P450, on the other hand, is a monooxygenase that
activates dioxygen to catalyze the hydroxylation of hydrocarbons. Therefore, it is
important to define the structural details that differentiate the chemical activities
demonstrated by CPO and P450.
CPO, with 299 amino acids, is a single polypeptide consisting of eight helical
segments and one small β pair. Structurally CPO has a P450-like proximal heme
environment with cysteinate sulfur as the axial ligand and a peroxidase–like distal heme
pocket in that polar residues form the peroxide-binding site, and was thus considered as a
P450-peroxidase hybrid (20). Despite the functional properties shared with other
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peroxidases and P450s, the tertiary structure of CPO bears little resemblance to either
peroxidases or P450s. In the CPO distal pocket, though polar as in other peroxidases, a
glutamic acid instead of a histidine is responsible for the cleavage of the O-O bond in the
formation of Cpd I (Fig. 1.8).

Figure 1.8 Proposed mechanism of compound I formation catalyzed by Chloroperoxidase.

In this mechanism, the activation of hydrogen peroxide is initiated by its binding to
the heme in the distal side. The deprotonated Glu183 abstracts a proton from the substrate
hydrogen peroxide, and then the formed hydroperoxo-anion binds to the heme iron,
yielding a ferric-hydroperoxo species known as Compound 0. Glu183 then protonates the
distal oxygen of Cpd 0 and the peroxide O-O is cleaved heterolytically to generate Cpd I
and release a water molecule, similar to other peroxidase mechanisms (107, 108). CPO is
adept in catalyzing a number of chiral oxidations with high yields and high
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enantioselectivity, in addition to alkyne hydroxylation and heteroatom dealkylation
(109-114). The stereoselective ability of CPO in catalysis is suggested to be based on its
unique active site structure and unique catalytic mechanism, which make it the promising
candidate for industrial catalysts.

1.4 PROTEIN ENGINEERING OF P450S AND HEME PEROXIDASES
Heme-containing proteins are primary targets of enzyme engineering because of their
distinct activities and versatile functions. The diversity of function and spectroscopic
characteristics of this class of proteins have been attributed to the structural components
and interactions around the heme prosthetic group, especially the identity of the proximal
axial ligation and the residues located in the distal pocket. The hemoproteins have been
extensively studied by protein engineering to help test structure-based mechanistic
hypotheses and evaluate the roles of important residues in enzyme catalysis, which often
involves the change of substrate specificity, reaction selectivity and efficiency of the
enzymes.
As mentioned before, cytochromes, globins, and most peroxidases utilize histidine as
the proximal ligand, while cytochromes P450, chloroperoxidase and nictric oxide
synthase use a cyseine thiolate ligand. Together with biochemical, biophysical and X-ray
crystallographic techniques, site-directed mutagenesis studies have greatly contributed to
the understanding of the structure-function relationships of hemoproteins and the key
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structural features governing the variability by achieving structural mimics of different
proteins. Substitution of the amino acids in the active site could make it possible to alter
the protein axial ligand and to explore the interconversion of functions among
hemoproteins, based on structure comparisons. In the following section, the mutagenesis
results that demonstrate the importance of protein structure in controlling heme activity
and the ability to engineer functions in some important examples of peroxidases and
P450 are described.
1.4.1 Cytochrome c peroxidase H52L & H175C
Like many other heme peroxidases, cytochrome c peroxidase (CcP) belongs to the
heme-imidazole protein family with a histidine serving as the axial ligand (H175) to the
heme iron. In the distal side of the heme group, there is a conserved histidine residue
(His52) (81). To investigate the role that histidine plays in the reaction of CcP with
peroxide, His52 was replaced with a nonpolar leucine residue. Although no dramatic
changes in the structure or in the accessibility of heme binding sites were observed, the
H52L mutant displayed a 105-fold decrease in catalytic rate compared with that of the
wild type (115). In addition, the reactivity of the H52L mutant with peroxide was pH
dependent and affected by the buffer. The pH-dependent study of this mutant has
indicated that the distal histidine plays crucial roles in the rapid reaction of CcP with
peroxide and it is more complex than simply being a base catalyst during the initial
formation of Cpd I (116).
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On the other hand, the proximal histidine ligand has been substituted by a cysteine.
The successful introduction of a thiolate ligand into a peroxidase system naturally with
histidine axial liagtion would shed light on the roles of His and Cys in the catalytic
activities of peroxidases by comparing the structure and function of the two heme
ligations in similar surroundings. In addition, by monitoring the changes in the structural,
functional and spectroscopic properties of the switched thiolate ligation could offer
insight into the question about how the thiolate-heme center performs such distinct and
diverse functions in various hemoproteins. The initial attempt to prepare a thiolate-ligated
CcP H175C mutant led to Cys oxidation to cysteic acid (117). In the crystal structure
studies of P450 and CcP, it has been shown that P450 has a hydrophobic environment
surrounding the proximal thiolate ligand provided by a conserved Phe residue, while in
CcP there is a negatively charged Asp which forms hydrogen bonds to the proximal
His175 ligand. The Asp235 residue was proposed to be critical in forming a stable
heme-thiolate ligation in the resting state of the CcP H175C variant (30).
1.4.2 P450cam C357H
In cytochrome P450cam, the crystal structure has demonstrated that the specific
cysteine bound to the heme iron is Cys357 (70). To investigate the functional and
structural roles of the proximal thiolate ligand in P450cam, the axial Cys357 has been
replaced by a histidine (118, 119). The importance of the thiolate coordination for the
P450 activities has been exemplified by their inactive forms P420, in which the thiolate
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ligation is lost (120, 121). The P450cam C357H mutant exhibits greatly decreased
camphor oxidation activity, and the heterolytic/ homolytic ratio of the O-O bond cleavage
in the reaction with cumene hydroperoxide, also the electron transfer rate is much slower
than that of the wild type. However, the mutant shows greater peroxidase activity because
of the axial ligand alteration. To clarify the roles of the thiolate coordination in the
heme-thiolate proteins, the axial histidine of myoglobin has been replaced with a cysteine
(Mb H93C) and the altered thiolate ligand accelerates the heterolytic scission of peroxide
O-O bond and enhances the styrene epoxidation activity aided by hydrogen peroxide.
These results have confirmed the important roles of the thiolate ligand plays in
hemoproteins play in facilitating the O-O bond cleavage to form the active intermediate
Cpd I and in protein folding, substrate binding and electron transfer.
1.4.3 CPO C29H & CPO E183H
Chloroperoxidase (CPO) is unique in structure since it shares features with both
peroxidases and P450 enzymes. As in cytochromes P450, CPO has a cysteine heme
ligand (Cys29) in the proximal side of the heme prosthetic group. However, in contrast to
the results of P450cam C357H, the thiolate coordination in chloroperoxidase is suggested
to be not as important as in P450. After substituting the proximal thiolate ligand (Cys 29)
with a histidine, the CPO C29H was found to retain most (around 80%) of its chlorination,
peroxidation, epoxidation and catalase activities compared to those of the wild type
protein (114). These are surprising observations in consideration of many suggestions for
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the significance of the proximal thiolate ligand in P450. These unexpected results could
be interpreted by the different mechanisms of the heterolytic O-O bond cleavage in CPO
and P450 catalytic cycles.
As the results of CPO C29H mutant downplayed the importance of thiolate ligation
in CPO activity, it has been suggested that the distal environment of the heme active site
plays the major role in controlling the versatile functions of this enzyme. Although, like
peroxidases that have polar distal pocket, CPO does not possess a histidine residue which
is normally conserved in the distal helix as the general acid-base catalyst in the formation
of Compound I. Instead, a glutamic acid at position 183 distal to the heme group takes
over this function, based on the crystal structure of CPO (20). To investigate the role
E183 plays in CPO catalysis, it has been replaced by a histidine residue. The results have
shown that this substitution is destructive to CPO activity, especially its chlorination and
dismutation activity, which are reduced by 85% and 50%, respectively (122). This
indicated that Glu-183 is important but not essential to the chlorination and the catalase
activity of CPO. However the epoxidation activity of the CPO E183H mutant was
surprisingly increased by about 2.5 times than that of the wild type. The crystal structure
of CPO identified a proton shuttle among Glu183, His105, and Asp106. Replacement of
glutamic acid with a hisitidine could partially destroy the triad, resulting in the inhibition
of chlorination activity but acceleration epoxidation activity.
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In summary, mutagenesis studies have shown that the axial ligands in P450s and
peroxidases do play essential roles in their catalysis. Key factors that determine the
functional specificity of hemoproteins include the nature of the proximal ligands as well
as the architecture of the distal site. The remainder of the dissertation details my effort to
tailor heme-thiolate proteins, specifically cytochrome P450cam, into efficient biocatalysts
with high specificity and selectivity by redesigning the protein through change of
residues in the distal pocket, in an effort to elucidate the key structural and functional
roles of critical amino acids in this protein.
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Chapter II. SINGLE AMINO ACID SWITCH TURNS P450CAM FROM A
MONOOXYGENASE INTO AN EFFICIENT PEROXIDASE

2.1 SUMMARY
Most heme peroxidases contain a highly conserved histidine that serves as the
general acid-base catalyst at the distal side of the heme prosthetic group in the formation
of compound I. In contract, cytochromes P450 do not have such obvious acid-base
groups in their hydrophobic distal heme pockets. To explore the possibility of engineering
cytochrome P450cam into an efficient peroxygenase via the “peroxide-shunt” pathway,
Val247 located closely to the heme iron in the distal helix has been substituted with a
histidine residue. The V247H mutant shows essentially identical optical spectral features
compared to those of wild type P450cam in the absence of substrate camphor, suggesting
that the heme-Cys ligation in the parent protein is kept intact in the mutant. Surprisingly
this mutant does not bind camphor like the wild type, possibly due to unfavorable
conformational changes in the distal helix which prevents camphor from entering the
substrate binding site in the same way. However, the V247H mutant has acted as a
self-sufficient enzyme with significantly higher peroxidase activity compared with wild
type protein, showing even higher activity than chloroperoxidase. Various spectroscopic
studies including UV, RR, CD and NMR coupled with electrochemical studies have
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provided insights into the structural changes that correlate with the observed catalytic
activities of this mutant.

2.2 INTRODUCTION
Cytochromes P450 constitute a superfamily of heme-containing monooxygenases
that are found ubiquitously in many bacteria, all archaea, fungi and many higher
eukaryotes. The P450 enzymes are involved in the activation of dioxygen for the
insertion or addition of one atom of oxygen to a wide variety of substrates, making them
crucial to many biotransformations such as steroid hormone biosynthesis, drug
metabolism, detoxification of xenobiotics, and molecular signaling (1-3). The reactions
catalyzed by P450s include epoxidation, dealkylation, hydroxylation, dehalogenation, and
heteroatom oxidation (4). The most distinctive structural feature of cytochromes P450 is
the coordination of a deprotonated cysteine to the heme iron as the proximal ligand, while
many other hemoproteins possess a histidine at the proximal side. Thus P450s belong to
the family of so-called heme-thiolate proteins, together with choloroperoxidase (CPO)
from Caldariomyces fumago, nitric oxide synthase (NOS), cystathionine β-synthase, and
etc. The proximal thiolate ligand in P450s has been proposed to play a vital mechanistic
role in providing the “push” effect which enables the heterolytic O-O bond cleavage to
generate activated iron (IV)-oxo porphyrin radical cation species commonly called CpdI,
leading to subsequent substrate oxidation (5-7).
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The typical P450 catalytic cycle involves substrate binding, dioxygen binding,
two-electron transfers, followed by CpdI formation and substrate oxidation. With a few
exceptions, the catalysis of the diverse reactions by P450s all require an external source
of reducing equivalents and auxiliary proteins (e.g., putidaredoxin, and puridaredoxin
reductase for P450cam). The requirement of expensive cofactors and the complication
caused by additional proteins is the limitation to the application of P450s as oxygenases.
Some P450s are capable of accepting hydrogen peroxide or an organic peroxy compound
as an oxidant to catalyze oxygen insertion through the so-called “peroxide-shunt”
pathway in the absence of electron transport proteins and the NAD(P)H cofactor (8-13).
However, P450s are typically not efficient in their utilization of hydrogen peroxide, the
natural substrate for peroxidases, as the source of oxygen atom in the monooxygenation
reactions.
Serving as the prototype member in the superfamily, cytochrome P450cam from
Pseudomonus putida has been extensively studied using various physical and chemical
techniques. It catalyzes the regio- and stereo-specific hydroxylation of its natural
substrate d-camphor to 5-exo-hydroxy-camphor (15). A great deal of effort has been
made to suitably engineer this enzyme by directed evolution and active site modification
for the oxygenation of significant unnatural substrates. It is still quite important to
understand the roles of the active-site components in the reactivity, stability, specificity
and substrate recognition of this enzyme after its discovery decades ago.
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To explore the possibility of converting P450cam into an efficient self-sufficient
peroxidase, we attempted to modify the heme distal side elements that play crucial
mechanistic roles in this protein’s catalytic functions. In most heme peroxidases, a distal
histidine is highly conserved in the active site and serves as a general acid-base catalyst
that is necessary for the formation of CpdI by donating a proton to the Fe3+-OOH moiety
to promote the heterolytic cleavage of the O-O bond in the peroxidase reaction cycles
(16-19). It has also been proposed that a functional nitrogen (such as the nitrogen of
His42 in HRP or His52 in CcP), located at a suitable distance from the heme iron, can
behave as an acid-base catalyst in hemoproteins (16, 20). Additionally, some unique P450
enzymes have been shown to function as peroxygenases by utilizing hydrogen peroxide
as the oxygen donor with extremely high catalytic turnover rates compared to their
normal monooxygenation reactions as well as the peroxide shunt reaction catalyzed by
the common P450s (12, 21). A common structural feature about these proteins is that the
distal side of the heme molecule is quite hydrophilic, which allows H2O2 to enter the
active site followed by the formation of CpdI with the interaction of the carboxyl group
of substrate and the Arg residue located near the heme (12).
In contrast, P450cam possesses a very hydrophobic distal environment that lacks the
distal machinery of the peroxidases mentioned above. Therefore, to probe the roles of the
nonpolar amino acids in the distal helix and to make an efficient peroxygenase, we
substituted a distal residue with a hydrophilic histidine which is highly conserved in other
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heme peroxidases. In the distal pocket of P450cam, camphor is bound in a specific
orientation above the heme iron, with a hydrogen bond between the camphor carbonyl
and the phenol side chain of Tyr96 as well as numerous non-covalent contacts with active
site residues (22). Val247 is one of the neighboring residues in the distal pocket that have
hydrophobic contact with the substrate camphor (23). In light of its proximity to the heme
prosthetic group, it served as a logical choice for our target (Fig. 2.1). The substitution of
Val247 with a histidine was anticipated to provide a functional nitrogen from the
imidazole group of His247 that could act as an acid-base catalyst via the peroxide-shunt
pathway to facilitate the generation of Cpd I that affords substrate oxidation.
Various spectroscopic techniques were utilized in the present work for the structural
and functional characterizations of the P450cam V247H mutant. In addition to electronic
absorption spectroscopy, resonance Raman spectroscopy is well established as a highly
sensitive probe of the active-site structure of heme proteins by providing detailed
structural information on iron spin and ligation states. Circular dichroism was performed
to examine the secondary and tertiary structural changes of the mutant. Proton nuclear
magnetic resonance spectroscopy, one of the most powerful methods for high resolution
structural characterization of paramagnetic metalloproteins, was also utilized to
characterize the active site structure of the cyanide complexes of the wild type and
mutant proteins.
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Figure 2.1 The active site structure of camphor-bound cytochrome P450cam: the heme
(salmon), camphor (gray) and some selected residues including distal V247 (green) in
P450cam are shown. The figures were generated from the crystal data (PDB code 2CPP) using
PYMOL (22).
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Additionally, redox potential measurements of the protein were performed to show the
effect of the amino acid substitution on the redox property of the heme iron.

2.3 EXPERIMENTAL PROCEDURES
2.3.1 Materials
The PfuUltra High-Fidelity DNA polymerase used for site-directed mutagenesis was
from Stratagene and the primers for the mutation were synthesized by Eurofins MWG
Operon (Huntsville, AL). Dithiothreitol (DTT), carbon monoxide, hydrogen peroxide, 2,
2’-Azino-bis (3-Ethylbenzthiazoline-6-Sulfonic Acid), and - aminolevulinic acid were
purchased from Sigma-Aldrich (St. Louis, MO). Yeast extract, tryptone, glycerol, sodium
chloride, sodium bromide, sodium acetate, sodium dithionite, potassium chloride,
potassium phosphate, potassium cyanide, potassium hydroxide, EDTA, Tris-HCl,
isopropyl-β-D-thiogalactopyranoside (IPTG), Ribonuclease A, Deoxyribonuclease I,
phenylmethylsulfonyl fluoride (PMSF), lysozyme, hemin, DL-tyrosine and DL-camphor
were obtained from Fisher Scientific (Pittsburgh, PA). DEAE sepharose fast flow and
Sephadex G-75 were purchased from GE Healthcare (Piscataway, NJ). All chemicals
were used without further purification. Choloperoxidase (CPO) from Caldariomyces
fumago was prepared in our own lab with Rz value over 1.40.
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2.3.2 Bacterial strains, plasmids and DNA manipulations
The bacterial strains used were E. coli NovaBlue and E. coli Rosetta II (DE3) from
Novagen (Gibbstown, NJ). The plasmid pUS200, constructed by Unger et al., contains a
1578-bp fragment of P. putida (ATCC 17453) P450cam plasmid fragment inserted into
the PstI and HindIII sites of pEMBL8+ (24). To increase the protein yield, the P450cam
gene was constructed into a T7-based expression vector, pET-30a (+) from Novagen, at
the sites of NdeI and HindIII by polymerase chain reactions and ligation reactions.
Bacteria were grown in Luria-broth supplemented with antibiotic (kanamycin, 100 μg/ml)
for the DNA manipulation. Site-directed mutagenesis was performed by using this
T7-based expression vector, pET-30a (+). The V247H mutant of P450cam was prepared
with the 5’-sense oligonucleotide 5’- CTG TTA CTG CAT GGC GGC CTG GAT-3’
coding for LLLHGGLD. The reconstituted plasmids of both wild type and V247H
mutant were transformed into E. coli strain NovaBlue and verified by DNA sequencing.
2.3.3 Protein Expression and Purification
The wild type P450cam and mutant V247H were expressed in Escherichia coli
strain Rosetta II (DE3). Cells were grown on terrific broth supplemented with 100mg/L
of kanamycin at 37 ˚C and induced with 1mM IPTG and 1mM camphor at OD600 around
0.8, followed by further growth at 30°C for another 18h prior to harvesting cells. As for
the mutant, the addition of δ-aminolevulinic acid to the growth media is necessitated to
facilitate holoenzyme production.
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Cells were lysed at 4°C in 50 mM Tris-HCl buffer at pH 7.4 containing 50 mM KCl,
0.5 mM DTT, 1 mM camphor, 1 mM EDTA, 200 μM PMSF, 40 U/ml Dnase I, 3 U/ml
Rnase A, and lysozyme. Following sonication and centrifugation, the lysate were
concentrated by Amicon cell with 30,000 Da cut-off ultrafiltration membrane. The
protein solution was applied onto a fast flow DEAE Sepharose column (50 ml)
equilibrated with 50 mM Tris-HCl buffer (pH 7.4). After initial elution, the column was
eluted with a linear 0-0.5 M KCl gradient in the same buffer. The red fractions containing
the ~45 kDa proteins were pooled for further purification by size exclusion
chromatography. Sephadex G-75 matrix (500 ml) was used for the gel filtration and the
buffer used was 100 mM potassium phosphate containing 1mM camphor at pH 7.4.
Substrate-free WT P450cam and its mutant were prepared by dialyzing the protein
samples against phosphate buffer without camphor, followed by centrifugation with a
microconcentrator (Centricon-30). Unless otherwise specified, all the steps in the protein
purification were performed at 4 °C.
The Rz values of pure wild-type P450cam and V247H mutant were over 1.4 and 1.3
respectively. The protein concentration was determined using the Soret extinction
coefficient determined by the pyridine hemochrome method following the standard
protocol (25, 26). The extinction coefficients for the camphor bound WT at 392 nm and
mutant enzyme at 416 nm were 102 and 115 mM-1cm-1 respectively. These values were
found to be 115 and 116 mM-1cm-1 for the camphor-free forms of the WT and mutant
enzyme at 418 nm.
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2.3.4 Spectroscopic characterization
Optical characterization of the wild type P450cam and its mutant was performed at
room temperature on a Cary 300 spectrophotometer (Varian). The ferrous proteins were
prepared by the addition of an excess amount of sodium dithionite and CO adducts were
obtained by CO gas bubbling. The buffer used for the absorption measurements was
100mM potassium phosphate buffer with 1mM camphor at pH 7.4.
CD spectra were measured on a JASCO J-815 spectrometer at room temperature.
The secondary-structure spectral region (200-260 nm) of the spectra was recorded in a
quartz cuvette of 1 mm path length using about 2 μM enzyme. As for the
tertiary-structure spectral region (260-650 nm), it was recorded using about 20 μM
enzyme in a quartz cuvette of 1cm path length with or without camphor.
For resonance Raman data collection, the wild-type P450 and V247H mutant were
prepared in a septum-sealed, cylindrical quartz cell. Samples were reduced to the ferrous
form by first flushing the sample with argon and then injecting a molar excess of buffered
sodium dithionite solution. The rotating sample cell was irradiated with 4 mW of 413.1
nm laser light using a mixed krypton/argon ion laser (Spectra Physics, Beamlok 2060).
The spectral acquisition time was 5 min. The scattered light was collected at right angles
to the incident beam and focused onto the entrance slit (125 μm) of a 0.8 m spectrograph,
where it was dispersed by a 600 groove/mm grating and detected by a liquid-N2-cooled
CCD camera (Horiba-JY). Spectral calibration was performed against the lines of
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mercury. UV-vis spectra of each sample were collected before and after each RR
measurement to ensure the sample integrity.
Proton nuclear magnetic resonance (1H NMR) spectra for the cyanide-bound
proteins were recorded at 298 K on a Bruker Avance 600 (Ultrashield) spectrometer
operating at a proton frequency of 599.97 MHz. Protein samples for NMR experiments
were prepared in D2O buffer solutions containing 100 mM potassium phosphate at pH 7.4,
by at least four isotope exchanges of the protein solution in H2O with D2O buffer. The
isotope exchanges were carried out in a microconcentrator (Centricon-30) at 4 °C. All
NMR samples contained more than 2 mM protein and the cyanide adducts of the protein
were prepared by the addition of a 10-fold to 20-fold molar excess of cyanide from a
freshly made 1M stock solution of KCN in 99.9% D2O. The residual solvent signal was
suppressed with presaturation during relaxation delay. Chemical shift values were
referenced to the residual HDO signal at 4.76 ppm.
Phase-sensitive NOESY spectra for the cyanide-bound derivatives of P450cam and
its V247H mutant were acquired with mixing times ranging from 1.5 to 25 ms. Typical
NOESY spectra were collected with 256 experiments in the F1 dimension using the
hypercomplex method (27). In general, 1600-2000 scans were accumulated for each F1
experiment, which was acquired with 4096 complex points in the F2 dimension over a
spectral width of 27 or 60 kHz. The residual solvent signal in all NOESY experiments
was suppressed using a 200-ms presaturation with a weak decoupler power.
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All the spectroscopic experiments were done with freshly prepared samples in
100mM potassium phosphate buffer (pH 7.4).
2.3.5 Redox measurements
The electrochemical measurements of wild type P450cam and V247H mutant were
performed with a CHI 660 electrochemical analyzer (CH Instruments) at room
temperature by using a conventional three electrode cell, with a glassy carbon (GC)
electrode as the working electrode, platinum wire as counter electrode and Ag/AgCl
electrode as the reference electrode. The carbon electrode has been modified with
single-walled carbon nanotubes (SWCNT). The preparation of the SWCNTs was carried
out as reported (28) and SWCNT suspension was cast onto the electrode and dried under
infrared lamp. The SWCNT modified electrode is electrochemically activated by cyclical
scanning between -1.0 and +1.5V at a scan rate of 1 V/sec for 2 minutes to improve the
sensitivity of the electrode. The redox potentials of P450camV247H mutant and the wild
type protein were obtained and normalized with the reference to NHE.
2.3.6 Peroxidase activity
The peroxidation activity of the V247H mutant was measured by using
2,2’-azino-bis-3-ethy-benzthiazoline-6-sulfonic acid (ABTS) as the electron donor and
hydrogen peroxide as the sole oxidant (29). The reaction was initiated by the addition of
H2O2 (3.3mM) into the reaction solution of enzyme (2μM) and ABTS (9.1 mM) in
100mM potassium buffer from pH 5.0 to pH 7.4. Wild type P450cam and
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chloroperoxidase were also examined at pH 5.0. Chloroperoxidase from Caldariomyces
fumago was prepared in our own lab, and the Rz value of the protein used in this assay
was over 1.4. The peroxidase activity was monitored at 405 nm, and the initial rate of
oxidized ABTS product formation was used to calculate the activity.

2.4 RESULTS
2.4.1 UV-visible Spectroscopy study
The UV-vis spectra for the ferric, ferrous, and ferrous-CO forms of V247H mutant
were obtained to examine the coordination structure of the heme iron both in the absence
and presence of camphor (Fig. 2.2A and 2.2B). The substrate-free V247H exhibited
essentially identical spectra to that of the wild type enzyme. However, the camphor
binding was perturbed in this mutant as compared to that in wild type according to the
optical characterizations. Instead of having the Soret band shifted from 418 nm to 392 nm
upon camphor binding, which is characteristic of the conversion of low-spin to high-spin
Fe (III), the mutant only displayed a 2 nm blue shift from 418 nm to 416 nm. Therefore,
the substrate-bound V247H mutant remained predominantly in the six-coordinate,
low-spin ferric iron state, similarly as reported in the G248E mutant of cytochrome
P450cam (30). The shape of the Soret band of camphor-bound V247H was also different
from that of the camphor-free protein, with less symmetry and a less prominent δ-band
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Figure 2.2. UV-vis spectra of P450camV247H in various oxidation states: (A) camphor-free and
(B) camphor-bound forms in 100mM phosphate buffer (pH7.4) at room temperature.
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feature at around 360nm, which is an indication of a sixth water ligand bound to the heme
iron. Otherwise, there were only very small differences in the visible absorption bands
(Table 2.1).
Table 2.1. Wavelength and extinction coefficients of absorption maxima for wild type and
V247H mutant of cytochrome P450cam

Protein

Oxidation state

Soret (nm)

-band (nm)

Visible (nm)

Fe3+

418 (392)

360

535，569

Fe2+

408

540

Fe2+-CO

446

550

Fe3+

418 (ε=116)

Fe2+

409

540

Fe2+-CO

447

548

Fe3+

416 (ε=115)

Fe2+

409

542

Fe2+-CO

447

550

WTP450
(camphor-free)

361

537，569

V247H
camphor-free

355

534, 569

V247H
camphor-bound

It is worth mentioning that for both camphor-free and camphor-bound samples, the
ferrous complexes displayed the Soret maximum initially at approximately 412nm upon
reduction, but the addition of more sodium dithionite or mixing for a longer time period
led to the Soret band shifting to 409nm. That could be an indication of the changed (most
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likely increased) electron density on the thiolate in the reduced state (31). The CO-bound
form of V247H showed a Soret maximum at 447nm, which supports the presence of an
intact iron-sulfur coordination in this mutant (32). In addition, the ligand binding activity
of the V247H showed very similar results compared with that of wild type. For example,
the KCN binding of V247H mutant displayed about a 24 nm red shift of the Soret band to
440 nm (Fig. 2.3), almost identical to that of the WT P450cam (33).
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Figure 2.3. UV spectra of P450camV247H and its KCN bound complex. The enzyme
concentration employed was ~4μM, and 10μl of 1M KCN was added to the enzyme.

2.4.2 Circular Dichrosim spectroscopy study
Multi-wavelength CD studies of the wild type and V247H mutant P450cam were
carried out to investigate the effect of the distal residue substitution on the conformational
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Figure 2.4. Far-UV CD (A) and visible CD (B) spectra of substrate-bound forms of the WT and
V247H mutant of cytochrome P450cam.
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properties of the enzyme. As shown in Fig. 2.4 A, the far-UV CD bands from 200-260 nm,
which provide information on the secondary-structural features of the proteins, showed
no significant difference between the wild type and the mutant, suggesting that the
mutation of the valine residue had no detectable effect on the secondary structure of the
protein. However, in the near-UV-visible CD region (300-650 nm), the camphor-bound
V247H mutant displayed rather different spectra in its ferric form from those of the wild
type (Fig. 2.4 B). This was consistent with the result of optical absorption measurement
that exhibited similar properties with the substrate-free wild type protein.
2.4.3 Resonance Raman Spectroscopy study
To examine the heme environment and the iron spin and ligation state of wild type
P450cam and V247H mutant, we obtained resonance Raman spectra in the absence and
presence of camphor. For the camphor-free ferric species, both wild type and V247H
mutant displayed a strong oxidation state marker band υ4 at around 1370 cm-1 typical of
ferric (Fe3+) heme (Fig. 2.5A). The heme core-size marker bands υ3 and υ2 appeared at
approximately 1500 and 1580 cm-1, respectively for the camphor-free samples, indicating
a six-coordinate (6C), low-spin (LS) heme iron (34-36). For the camphor-bound proteins,
the V247H mutant showed a different pattern from the wild type. Whereas the wild type
displayed the υ3 and υ2 bands at 1486 and 1568 cm-1, indicative of five-coordinate (5C),
high-spin (HS) heme iron component, the V247H displayed peaks at 1499 and 1581 cm-1,
consistent with a 6C-LS complex, similar to the camphor-free samples. The RR spectra of
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ferrous P450cam and V247H with camphor bound showed a υ4 band at 1344 cm-1,
consistent with thiolate proximal ligation (Fig. 2.5B) (37). The υ3 and υ2 band positions of
these two samples at 1465 cm-1 and 1562 cm-1 confirmed that the ferrous forms of both
wild type and mutant complexes were 5C-HS. However, the ferrous forms of
substrate-free wild type and mutant proteins displayed a different spectral pattern from
the camphor-bound forms. Most notably, the υ4 band appeared at 1358 instead of 1344
cm-1, indicating a loss of or modulation of the proximal thiolate ligation. However, for the
wild type, there was a 1344 cm-1 shoulder of the υ4 band, indicating that a weak
population of thiolate proximal ligand was retained.
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Figure 2.5. Resonance Raman spectra of (A) ferric and (B) ferrous wild-type P450 and
P450V247H mutant with and without camphor binding. The excitation wavelength (λex ) was
413.1nm. The spectra of P450 and V247H samples in the presence and absence of 1mM camphor
are shown.

2.4.4 NMR Spectroscopic study
Figure 2.6 showed the 1D proton NMR spectra of ferric low spin, cyanide-bound
complexes of both wild type and V247H mutant of P450cam in the presence of camphor.
The wild type P450cam exhibited almost identical results as repored in the literature, with
two broad, fast relaxing, strongly hyperfine-shifted peaks at 33.1 ppm and -21.4 ppm
respectively, indicative of the β protons from the coordinated Cys357 (38).
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Figure 2.6 600-MHz 1H Nuclear Magnetic Resonance spectra of the low spin cyanide complexes
of (A) wild-type P450 and (B) V247H mutant. The spectra are collected at 298K in 0.1 M
phosphate buffer at pH7.4.

Chloroperoxidase also shows a similar spectral pattern with that of P450cam with
two hyperfine-shifted peaks at 38.3 and -20.7 ppm, the characteristic features of protons
in close proximity to the heme iron from Cys29 (27). The P450cam V247H mutant (Fig.
2.6 (B)) displayed similar results, but with a slight shift compared with the wild type,
which could be the result of conformational change caused by the substitution of the
distal Val247. Nevertheless, the pair of peaks at 30.9 ppm and -19.8 ppm suggested the
thiolate ligation in the V247H mutant was remained.
2.4.5 Electrochemistry study
Various reconstituted hemoproteins with modified heme or associated residues have
been measured to analyze the factors that control their functions (39-41). However, the
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Figure 2.7 Cyclic voltammograms of WT P450cam and V247H mutant on a glass carbon
electrode modified with SWNTs in the presence (A) and absence (B) of substrate camphor.
Voltammograms were recorded between -1.0 and +1.5V at the scan rate of 1V/sec in 100mM
phosphate buffer (pH7.4).

63

direct determination of the redox properties of heme proteins is often rendered difficult
due to the strong adsorption of the protein onto electrode surface. The use of
SWNT-coated carbon electrodes virtually eliminates this problem.
The reduction potentials for wild type P450cam were measured to be -304 and -135
mV in the absence and presence of camphor, respectively, both of which were in good
agreement with the reported values (42). While the formal potential for the camphor-free
V247H mutant was observed, to be much greater than the wild type, as high as +256 mV,
upon substrate binding the value was decreased by about 50 mV to +206 mV (Fig. 2.7).
This suggests that the substitution of the distal valine residue with a histidine induced a
positive shift of the Fe3+/Fe2+ redox couple that might be attributed to the conformational
change in the distal pocket.
2.4.6 ABTS assay
As shown in Fig. 2.8, the V247H mutant exhibited significant peroxidase activity
compared with the wild type protein, and its reactivity was enhanced dramatically as pH
increased. The highest peroxidation reactivity of the V247H mutant was observed at pH
7.4, which is the physiological optimum pH for P450cam. It displayed even higher
peroxidase activity than CPO, and about 700-fold increase compared with the wild type
P450cam at pH5.0.
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Figure 2.8 ABTS assay of cytochrome P450cam, V247H mutant and CPO at different pH values.
The peroxidase activity was monitored at 405nm in the presence of ABTS (9.1mM), enzyme
(2µM), and H2O2 (3.3mM) in 100mM potassium phosphate buffer. The initial slope of the
absorbance was used to calculate the peroxidase activity.
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2.5 DISCUSSION
Though P450s are potentially significant enzymes for catalyzing the insertion of
oxygen into unactivated C-H bonds, the practical application of cytochromes P450 as
industrial biocatalysts has been greatly limited by the requirement of expensive cofactors
and partner proteins. In this study, we converted the P450cam into an efficient peroxidase
without the aid of any auxiliary elements by replacing the significant distal amino acid
Val247 with a histidine residue. A distal His is found in many heme peroxidases and thus
V247H mimics their distal environment.
The ABTS assay, which serves as a typical method to examine the peroxidase
activity, was performed to test the mutant. We showed that after substitution of Val247
with a histidine, the mutant gained significantly higher peroxidase activity driven by
H2O2. Although in many heme peroxidases the distal histidine plays a key role in the
formation of CpdI, a nearby arginine residue (also highly conserved) has also been
suggested to cooperate with the histidine, thus playing an important role in assisting the
catalytic cycle (17, 43, 44). Considering the possible contribution that a distal arginine
might make to the peroxidase activity of V247H, we also replaced the nearby amino acid
L244 in the distal helix with an arginine. However this double mutant L244R/V247H
did not show higher peroxidase activity than the single mutant under the same conditions
of study (data not shown). Previously, the proximal Cys357 was substituted with a
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histidine to mimic heme peroxidases, but the V247H/C357H mutant did not exhibit better
“peroxidase” activity compared with V247H alone (45).
The V247H mutant of P450cam was characterized by various spectroscopic
techniques. UV-vis spectra showed that the resting state of V247H mutant without
camphor is a six-coordinate, low spin ferric heme complex, similar to wild type P450cam,
which has cysteinate and H2O serving as the axial ligands. However, in addition to the
wild type, V247H remained 6C-LS with addition of camphor. This suggests that the
camphor-bound V247H mutant still remains predominantly in the six-coordinated,
low-spin ferric iron state. This indicates that the camphor enters or binds to the heme
prosthetic group differently due to the possible conformational changes caused by the
replacement of Val247. The substituted bulkier histidine residue might sterically hinder
the entrance of the substrate by having the imidazole group oriented in the direction of
the heme iron. This was further confirmed with the CD spectroscopic study. Nevertheless,
the characteristic Soret band of the ferrous-CO complex of V247H appeared at around
450nm, suggesting that the V247H mutant maintains the proximal heme-thiolate
coordination. The reduced form of the mutant possesses a Soret maximum at 412nm upon
initial reduction, which probably implies increased electron density on the thiolate in the
reduced state (46).
Resonance Raman spectroscopy has proven to be a powerful probe to investigate the
heme environment, especially the coordination, spin state and axial ligations of the heme.
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In this study, both substrate-free and substrate-bound wild type and mutant proteins were
examined (Fig. 3.4). Overall the spectra of P450cam with camphor in different oxidation
states agree well with previous RR results (47, 48). The RR results of the ferric forms of
the mutant protein in the presence and absence of camphor are also consistent with the
UV-Vis absorption data discussed earlier.
The υ4 band in the RR spectrum of 5C-Fe2+ heme complexes is a useful diagnostic
marker of the identity of the proximal ligand.

RR studies of a wide variety of heme

proteins over the years have established that 5C-Fe2+ heme complexes with histidine
(imidazole) as proximal ligand produce a υ4 band in the 1350-1360 cm-1 region whereas
those with a cysteine (thiolate) proximal ligand display a υ4 band in the 1340-1348 cm-1
region (37, 49). The ferrous forms of camphor-bound wild type P450cam and V247H
mutant display a υ4 band in the range for 5C thiolate proximal ligation. Although the UV
absorption spectrum of the ferrous-CO complex of camphor-free V247H indicated that
the thiolate proximal ligand is preserved, the RR spectrum of the ferrous form does not
indicate the same based on the previously established signatures. Thus, the υ4 band is
located at 1358 cm-1, significantly higher than the expected 1340-1348cm-1 range for
proximal thiolate ligation (37). A υ4 peak at 1358 cm-1 was also observed for the
camphor-free wild type protein, although in this case a shoulder was observed at ~1344
cm-1. Evidently, in the absence of camphor, the proximal thiolate ligand is altered either
by being fully replaced by a histidine ligand, or by being protonated or elongated.
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Replacement of the cysteine ligand by a histidine appears unlikely because the CD data
did not indicate any significant conformational changes upon camphor binding (Fig. 3.4
(A)). Also, we substituted all of the histidine residues present in the distal helix with
either glycine or alanine and this species exhibited the same RR spectroscopic features
(see Chapter III).

Therefore it is likely that the proximal cysteine in the present case is

protonated rather than replaced by another proximal residue.

Indeed, Sabat et al.

recently showed that protonation of the proximal cysteine ligand in iNOS leads to similar
RR spectroscopic features as has been traditionally ascribed to a proximal histidine ligand
(50).
The electrochemistry of this mutant together with wild type P450cam has shown that
the distal environment can regulate the redox potential of the heme iron. For
heme-containing oxygenases and peroxidases, the “push-pull” mechanism has been
proposed where the generation of Cpd I is facilitated by an anionic proximal ligand
and/or positive polar distal residues (51). In peroxidases like horseradish peroxidase or
cytochorme c peroxidase, the “push” effect is provided by the proximal histidine and
“pull” effect is mainly provided by the distal histidine that serves as a general acid–base
catalyst to generate and stabilize the Cpd I (16, 52). For P450cam, since it lacks the distal
residue that could promote the heterolytic O-O bond cleavage, the strong “push” effect
from the proximal thiolate axial ligand is proposed to be responsive for the O–O bond
heterolysis. It has also been suggested that the total charge near the heme could be
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important for the heme redox potential. In the V247H mutant of P450cam, the redox
potential was greatly increased, over 300 mV higher compared with that of the wild type.
The increased redox potential of the V247H mutant clearly indicated the enhanced “pull"
effect because of the introduction of the distal hisitine residue which would increase the
total charge near the heme prosthetic group and facilitate the generation of Cpd I.
In summary, we have shown that the substitution of Val247 in the distal helix with a
hydrophilic histidine residue, which is highly conserved in many heme peroxidases, has
successfully converted P450cam into an efficient self-sufficient H2O2-driven peroxidase,
with the thiolate ligation intact in the proximal side.
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CHAPTER III. ENIGNEERING CYTOCHROME P450 INTO P420 WITH
CATALYTIC ACTIVITIES

3.1 SUMMARY
In an effort to engineer cytochrome P450cam into a self-sufficient biocatalyst, key
structural components within the heme active site of P450cam and chloroperoxidase
(CPO) were evaluated and the P450cam L246K mutant was constructed. L246K works as
a self-sufficient peroxidase demonstrating the importance of polarity of the distal heme
environment in regulating the catalytic property of P450cam. The similar UV-vis and
resonance Raman (RR) spectra of ferric L246K and substrate-free ferric P450cam
support a hexacoordinate, low-spin heme with thiolate ligation in this form of the mutant.
Surprisingly, the reduced L246K and its CO complex display spectral properties similar
to those of the inactivated species of P450cam (P420), suggesting the proximal ligand of
L246K was changed or modified during reduction and CO binding. Contrary to what has
been generally thought, formation of a myoglobin-like heme structure in L246K via
histidine coordination is ruled out by the expression of a P450cam mutant (L246K-3H,
H352G/H355G/H361A) where all three histidines located in the vicinity of the proximal
ligand helix were replaced by glycine or alanine. On the basis of the spectral similarities
and functional differences among L246K, the native P450cam, and the inactive P420, it is
proposed that upon reduction and CO binding, the proximal cysteine ligand of P420
becomes protonated due to harsh conditions employed in its preparation while the
proximal ligand of L246K retains the parent protein’s thiolate character but with a longer
Fe-S bond due to conformational changes induced by the mutation.
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3.2 INTRODUCTION
The cytochromes P450 are a ubiquitous class of heme-containing monooxygenases
named for their characteristic optical absorption maximum near 450 nm upon reduction
in the presence of carbon monoxide (1). They catalyze a variety of difficult chemical
transformations with high specificity and selectivity under physiological conditions,
making them attractive candidates for large-scale production of fine chemicals and
pharmaceuticals that are difficult to synthesize with standard organic chemistry (2-4).
Cytochrome P450cam (CYP101) from Pseudomonas putida catalyzes the
hydroxylation of camphor and has been extensively studied as the prototype of P450
monooxygenases because of its solubility, availability and extensive mechanistic and
structural characterizations. It was the first to be characterized by crystallographic
techniques among P450 enzymes (5). Previous study has shown that the resting state of
P450cam is a predominately low spin Fe (III) porphyrin with water cluster occupying the
sixth coordination position, upon substrate binding the water is replaced by the substrate
camphor and the complex becomes high spin followed by reduction to Fe (II) and
subsequent binding of O2 (6).
The P450s and chloroperoxidase (CPO) from Caldariomyces fumago are distinct
from most heme proteins in possessing a deprotonated cysteine residue at the proximal
side serving as the axial ligand to the heme iron (Fig. 3.1) (7-9). The role of axial-thiolate
ligation in P450s has been widely studied and the thiolate ligand is suggested to serve as
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a strong internal electron donor, facilitating the heterolytic cleavage of the dioxygen bond
to generate the activated iron (IV)-oxo species known as Cpd I (10, 11). Also the
presence of the cysteinate thiolate proximal heme iron ligand is believed to be
responsible for the red-shift of the Soret absorption band at 450nm. Although P450s and
CPO share similar metal binding sites, their heme environments are quite different in
terms of polarity (12). The active site of P450 is highly hydrophobic in nature with the
lack of obvious acid-base catalytic residues in close proximity to the oxygen binding
pocket, while CPO has evolved a more polar distal heme pocket analogous to that of the
hydro-peroxidases (13). Another dissimilarity between P450cam and CPO is that CPO
only needs hydrogen peroxide to be catalytically active, while P450cam requires
dioxygen, cofactor NADH and two electron-transfer proteins—putidaredoxin reductase
and putidaredoxin which are known as the “physiological partners” (14). These
requirements for activity are believed to be the major factors that hinder the application
of P450s in biotechnological processes. The goal of this study is to understand the
structure-functional relationships in hemoproteins and to investigate the feasibility of
converting P450cam to an active catalyst without cofactors and explore the correlation
and possible conversion between P450s and peroxidases (such as CPO).
Most P450 enzymes would undergo a universal denaturing transition to a stable but
inactive species known as P420s because the absorption maximum of the resulting
FeII-CO complex is at 420 nm rather than at 450 nm as is characteristic of P450 (15).
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Cytochrome P420 could be formed from all known types of P450 by numerous chemical
and physical techniques, such as incubation in organic solvents (16), exposure to high
temperature, pressure (17, 18), neutral salts (19), or to very low and high pH buffer (20).
P420 can sometimes, depending on how it is prepared, be converted back to P450 by
incubation with thiols, spermine, dimethyl sulfoxide, polyols, and native substrates (16,
22-25) . Therefore, knowledge about the structural relationship between the inactive P420
and the native P450 is of paramount importance to our understanding of the catalytic
activity and the nature of the putative transient intermediates involved in the catalytic
cycle of P450 enzymes. Furthermore, the structural alterations that occur during the
conversion of P450 to P420 will not only shed light on the conformational modification
in many hemoprotein variants with thiolate axial ligands, but also greatly help us in the
rational design of self sufficient P450 mutants with enhanced activity and stability.
In fact, there are some other P420 forms of the heme-thiolate proteins besides P450.
As a member of P450 family, inducible nitric oxide synthase (iNOS) possesses a
negatively charged thiolate ligand from a deprotonated cysteine residue proximal to the
heme iron (26). Like other P450 proteins, the reduced iNOS exhibits the absorption Soret
band at around 450nm upon CO binding (iNOSP450), which can spontaneously convert
to an inactive species like “P420” (iNOSP420) with the Soret band at around 420nm
(27-30). The spectroscopic studies have shown that the iNOSP420 species is inactivated
by protonation of the proximal thiolate ligand to a neutral thiol, instead of by ligand
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Thr252
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Asn74
Phe103

Cys29
Figure 3.1 Heme environmental structure of ferric cytochrome P450cam (A) and
chloroperoxidase (CPO: B): the heme (yellow), camphor (gray) and some selected residues
including distal Leu246 (salmon) in P450cam are shown. The figures were generated from the
crystal data (PDB code 2CPP and 1CPO) using PYMOL (5, 21).
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switching (e.g. to a histidine) (31). The iNOSP450 to iNOSP420 transition is controlled
by the conformational state of the enzyme. In addition chloroperoxidase, under alkaline
conditions, could also undergo a denaturating transition to an inactive species that has a
spectrum essentially identical to that of cytochrome P420, and is named C420 (32).
Although the conversion of CPO to C420 can be stopped at any point by lowering the pH,
it is not likely to convert C420 back to native CPO by adjusting the complex to lower pH
values or by adding natural sulfhydryl compounds such as mercaptides (33). The heme
iron oxidation state has been suggested to influence the transition to C420 which triggers
the conformational change. In ferric C420, the proximal ligand C29 appears at least
partially retained in a thiolate/imidazole coordination sphere. However the ferrous C420
loses the thiolate ligand and has a bis-histidine coordination structure instead. Upon CO
binding, one of the axial histidine liagnds remains trans to the carbon monoxide (32).
Although many physical and chemical methods have been employed to investigate
the structural features of P420 and its counterparts in iNOS and CPO, the structural
relationship between P450 and P420 remains controversial (22, 34-36). Postulation
concerning the structure of P420 has been focused on the nature of the proximal heme
iron ligand. In particular, it has been suggested that a conformational change results in
replacement of the thiolate ligand by histidine or exogenous ligand, yielding a myoglobin
(Mb)-like heme coordination structure (36-38). Alternatively, theoretical calculations and
recent studies with Mb H93G cavity mutant have indicated that the proximal thiolate may
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be protonated, resulting in a weaker thiol ligand (39, 40), or that the Fe-S bond might be
weakened by lengthening (41). Unfortunately, there is little experimental evidence in the
literature to distinguish these hypotheses (35, 42). Therefore, it is desirable to make a
P450 variant that does not need harsh physical and chemical treatment but displays
P420-like spectral features.
In an effort to engineer P450cam into a self sufficient catalyst, we designed several
mutants focused on modulating the polarity of the distal heme environment. As predicted
by the structural comparison of P450 with most heme peroxidases, introducing polar
residues to the heme distal environment indeed improved the catalytic efficiency of P450
dramatically. First, multiple mutations were carried out in P450cam to replace the
hydrophobic amino acids in the distal side of the heme group with polar amino acids. The
P450 variant was named as P450H with the substitutions of L244K, L245K, L246K,
L250K, T252H, V253A and V254R. The spectroscopic studies of P450H showed
P420-like properties in its ferrous and ferrous-CO complexes. To elucidate which one or
ones of the nonpolar residues in the distal pocket induced such transition, single mutation
and multiple mutations were performed. It turned out that the L246K mutant of P450 was
the first example that demonstrated typical spectral features of P420s but acted as a
self-sufficient catalyst. Through the process, the introduction of polar residues to the
heme distal environment indeed improved the catalytic efficiency of P450 dramatically.
More significantly, structural and biochemical studies of this P420-P450 hybrid allowed
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us to discern the nature of the proximal heme iron ligand in the active P450 and the
inactive P420 species.

3.3 EXPERIMENTAL PROCEDURES
3.3.1 Site-directed mutagenesis and protein expression.
The pUS200 plasmid used in this work, containing a 1578-bp CAM plasmid
fragment of Pseudomonas putida (ATCC 17453), was subcloned into the PstI and HindIII
sites of vector pEMBL8+. To increase the protein yield, the P450cam gene was
constructed into pET-30a (+), a high copy number vector, at the sites of NdeI and HindIII
by polymerase chain reactions and ligation reactions. The L246K mutant of P450cam was
prepared with the 5’-sense oligonucleotide 5’- ATG TGT GGC CTG TTA AAG GTC
GGC coding for MCGLLKVG. The L246K 3H mutant was obtained based on the L246K
mutant with the 5’-sense oligonucleotide 5’- TTT GGC GGT GGC AGC GGT CTG TGC
CTT GGC CAG GCA CTG GCC coding for FGHGSHLCLGQHLA. The primers used
for P450H, and other mutants were listed in Appendix C. The reconstructed plasmids
containing wild type P450cam and its P450H, L246K and L246K 3H mutants were
transformed into E. coli strain NovaBlue and verified by DNA sequencing. Then the
proteins were expressed in E. coli strain Rosetta II (DE3). Cells were grown on terrific
broth supplemented with 100mg/L of kanamycin at 37 ˚C and induced with 1mM IPTG
and 1mM camphor at OD600 around 0.8, followed by further growth at 30°C for another
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18h prior to harvesting cells. As for the mutants, the addition of δ-aminolevulinic acid to
the growth media is necessitated to facilitate holoenzyme production. The cells were then
harvested and frozen at -80°C.
3.3.2 Protein purification
Cells were lysed at 4°C in 50mM Tris-HCl buffer at pH 7.4 containing 50 mM KCl,
0.5 mM DTT, 1 mM camphor (buffer A), 1 mM EDTA, 200 μM PMSF, 40 U/ml Dnase I,
3 U/ml Rnase A, and lysozyme. Following sonication and centrifugation, the lysed cells
were concentrated by Amicon cell with 30,000 Da cut-off ultrafiltration membrane. The
protein solution was first applied on a fast flow DEAE Sepharose column. After initial
elution, the column was eluted with a linear 0-0.5 M KCl gradient in the same buffer. As
for the L246K and L246K 3H mutants, they were expressed as apo-proteins. So the
fractions containing the ~45 kDa proteins were pooled for heme reconstitution. Hemin
was added to the apo-protein dropwise and stirred overnight (43). After heme
reconstitution, the protein was again applied on the fast flow DEAE Sepharose column.
The reddish fractions of correct molecular weight were pooled and concentrated using a
Centriprep with an YM30 membrane for further purification by size exclusion
chromatography. The buffer applied on the gel filtration was 0.1 M potassium phosphate
buffer at pH7.4.
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P420 was prepared as reported by adding 30% acetone and incubate at room
temperature for 30 minutes (16). Unless otherwise specified, all the steps in the protein
purification were performed at 4 °C.
3.3.3 Electronic absorption spectroscopy
The UV-visible spectra of the P450cam mutants were recorded on a Varian Cary 300
Bio UV-visible spectrophotometer at room temperature. The ferrous proteins were
prepared by the addition of excess amount of sodium dithionite and CO adducts were
obtained by CO gas bubbling. The buffer used for the absorption measurements was
100mM potassium phosphate buffer at pH7.4.
3.3.4 Resonance Raman spectroscopy
For the resonance Raman data collection, the wild-type P450 and its mutant samples
with concentration about 50μM were prepared in a septum-sealed, cylindrical quartz cell.
Samples were reduced to the ferrous form by first flushing the sample with argon and
then injecting a molar excess of buffered sodium dithionite solution. The rotating sample
cell was irradiated with 4mW of 413.1nm laser light using a mixed krypton/argon ion
laser. The spectral acquisition time was 5 min. The scattered light was collected at right
angles to the incident beam and focused onto the entrance slit (125μm) of a 0.8m
spectrograph, where it was dispersed by a 600 groove/mm grating and detected by a
liquid-N2-cooled CCD camera (Horiba-JY). Spectral calibration was performed against
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the lines of mercury. UV-vis spectra of each sample were collected before and after each
RR measurement to ensure the sample integrity.
3.3.5 Peroxidase activity
2, 2’-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) was used as the
substrate for the enzymatic assay of peroxidase activity of wild type P450cam, P450H,
CPO, P420 and the P450cam L246K mutant protein. 9.1mM ABTS substrate solution
was prepared in 50mM phosphate buffer at pH5.0. Hydrogen peroxide was added to
initiate the reaction, and the increase of the absorbance was monitored at 405nm for 2
min. The spectrophotometer cell holder was equipped with a magnetic stirrer and the
incubation mixture was stirred throughout the reaction.

3.4 RESULTS AND DISCUSSION
3.4.1 Optical properties and catalytic activity of P450H
The P450H mutant of cytochrome P450cam, in which seven hydrophobic amino
acids were replaced by polar residues, showed very different electronic absorption
properties with those of the wild type in all oxidation states (Fig. 3.2). Especially, the
ferrous-CO complex of the P450H mutant displayed the absorption maximum at 420nm
instead of 450nm which is characteristic of P450. The blue shift of the spectrum could be
caused by the change of polarity in the distal pocket and some distinct conformational
alteration in the active site. To examine whether the P450H mutant with increased
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Figure 3.2 UV-visible spectra of P450H in various oxidation states.
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Figure 3.3 Peroxidase activities of wild type P450cam and its P450H mutant determined by
monitoring the oxidation of ABTS at 405nm in the presence of H2O2 (3.3mM), ABTS (9.1mM),
and enzyme (2μM).
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polarity in distal side gained some peroxidase activities, a peroxidase assay using ABTS
as the substrate was performed that showed greatly increased activity of P450H compared
with that of wild type protein (Fig. 3.3). These results suggested the modified distal
environment of P450cam induced some marked changes both structurally and
functionally.

3.4.2 UV-visible spectroscopic studies of P450L246K
To examine specifically which one or which ones of the seven substituted residues
in the distal pocket caused the dramatic change, single mutation and multiple mutations
were carried out. It turned out that the single mutant L246K exhibited quite similar
properties with those of P450H. The identity of the mutant proteins was verified by
SDS-PAGE. Changing L246, a non-polar residue located on the distal heme of the protein,
to lysine, a basic and polar residue resulted in a mutant typical of ferric low spin,
six-coordinate heme proteins as demonstrated by the electronic absorption spectra of the
mutant (Fig. 3.4). The absorption maxima of the spectra in Figure 3.4 are essentially
identical to those of the substrate-free wild-type P450cam and P420cam (Table 3.1),
suggesting that the proximal heme iron ligand, Cys357, in wild-type P450cam was
retained in the L246K mutant (34, 44). However, the electronic absorption spectra of the
ferrous and the ferrous–CO complex of the L246K mutant displayed absorption
maximum at 423 and 419 nm, rather than at 408 and 450 nm, respectively, expected for
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most heme thiolate proteins. It has been generally believed that these spectral features are
characteristics of hemoproteins with proximal histidine ligand (45).
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Figure 3.4 UV-vis spectra of P450camL246K in various oxidation states. The inset shows a
magnification of the spectra in the α/β band region. The enzyme concentration employed was
4μM.

However, histidine ligation in this case has been ruled out due to the following two
considerations. First, there is no histidine in the distal pocket of P450cam (9). Second, the
ferrous and ferrous-CO forms of the P450 L246K-3H mutant (H352G/H355G/H361A)
where all three histidines that locate in the vicinity of the proximal helix have been
replaced by glycine or alanine, display virtually identical optical absorption features to
those of P420 and L246K (Table 3.1). Therefore, it is proposed that the observed
absorption maximum at 420 nm in L246K and L246K-3H mutants as well as in P420 is
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due to milder changes such as protonation of the proximal ligand or lengthening of the
Fe-S bond caused by conformational changes induced by mutation or conditions used in
the preparation of P420 rather than more drastic changes such as ligand switching.
Table 3.1 Wavelength and extinction coefficients of absorption maxima for WT P450cam, P420cam,
P450camL246K and P450camL246K 3H

Soret (nm)

-band (nm)

Visible (nm)

Fe3+

417

360

535, 569

Fe2+

408

540

Fe2+-CO

446

550

Fe3+

422

Fe2+

424

530, 558

Fe2+-CO

420

540, 572

Fe3+

421

P450camL246K Fe2+

423

532, 558

Fe2+-CO

419

539, 567, 620

Fe3+

411

Protein
WT P450cam

P420cam (22)

P450camL246K Fe2+
3H
Fe2+-CO

367

362

360

541, 566, 651

540

535, 569

423

531, 558

420

540, 569, 621

Indeed, thiol-ligated ferrous heme-CO adducts of both synthetic heme model
compounds and biomimetic protein models display Sort absorption maximum at 420 nm
(39, 46) Alternatively, it has been reported that lengthening of the Fe-S bond by 0.2 Å
could induce the optical spectral transition of ferrous-CO complex of heme thiolate
proteins from ~450 nm to ~420 nm (34, 41). Alternatively, protonation of the native
proximal thiolate ligand to a neutral thiol could be responsible for the P420-like spectral
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pattern of both L246K and L246K-3H mutants. In fact, neutral thiol-ligated ferrous
heme-CO adducts of both synthetic heme model compounds and biomimetic protein
models displayed absorption maximum at 420 nm (39, 46, 47).
3.4.3 Resonance Raman spectroscopic study
The resonance Raman (RR) spectra of heme proteins are characterized in the high
frequency region by strong porphyrin in-plane vibrational bands, which are diagnostic of
the oxidation-, spin-, and coordination-state of the heme iron (48-50). To further examine
the heme environment of L246K and L246K-3H mutants together with wild type
P450cam and P420, we obtained resonance Raman spectra in various oxidation states.
The RR spectra of all the ferric protein samples displayed a strong oxidation state marker
band ν4 at around 1370 cm-1 that is typical for ferric (Fe3+) heme (Fig. 3.5 A). The
camphor-bound P450cam heme core-size marker bands ν 3 and ν 2 appeared at 1486 cm-1
and 1568 cm-1, respectively, indicating a five-coordinate (5C), high-spin (HS) heme iron
(51-53). While for all other samples, the spectra displayed the ν 3 and ν 2 bands at around
1500 cm-1 and 1580 cm-1, suggesting a six-coordinate (6C), low-spin (LS) heme iron
component. Overall the camphor-free, camphor-bound P450cam and P420 RR spectra
agree well with previous RR studies (54, 55). The spectra of both ferric L246K and
L246K-3H closely resemble that of ferric P420, with mainly 6C-LS heme iron in each
case (Fig. 3.5 A).
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Figure 3.5 Resonace Raman spectra of (A) ferric and (B) ferrous wild-type P450 (in the presence
and absence of 1mM camphor), P420, P450L246K mutant and P450L246K 3H mutant. The
excitation wavelength (λex ) was 413.1nm.

The ν4 band in the RR spectrum for 5C-Fe2+ heme complexes is a useful diagnostic
marker of the identity of the proximal ligand. RR studies of a wide variety of heme
proteins have shown that 5C-Fe2+ heme complexes with histidine (imidazole) as proximal
ligand produce a ν4 band in the 1350-1360 cm-1 region whereas those with a cysteine
(thiolate) proximal ligand display a ν4 band in the 1340-1348 cm-1 region (56, 57). The
RR spectrum of ferrous P450cam shows a ν4 band at at 1344 cm-1 that is consistent with
thiolate proximal ligation (Fig. 3.5B). The ν3 and ν2 band at 1465 cm-1 and 1562 cm-1
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confirm that the ferrous P450cam complex is 5C-HS. The RR spectrum of ferrous P420
also indicates a mainly 5C-HS complex but in contrast to P450cam the ν4 band occurs at
1357 cm-1, which is consistent with proximal histidine ligation (Fig. 3.5B). The RR
spectra of ferrous L246K and L246K-3H mutants are almost identical to that of P420,
thus ruling out the possibility that the high value for the position of the ν4 band is
associated with proximal histidine ligation in this case.
An alternative possibility is that for ferrous P420, L246K and L246K 3H mutants
the proximal ligand is the protonated cysteine (neutral thiol) form (58). Assignment of the
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Figure 3.6 Resonace Raman spectra of FeII–CO complexes of P450camL246K and L246K-3H
mutants in both low frequency region (A) and high frequency region (B).
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Fe–CO and C–O stretching modes of the FeII–CO complexes is useful because they are
influenced by the nature of proximal ligand and the polarity of the distal pocket
environment (59, 60). The RR spectra of the FeII–CO complex of L246K mutant in the
high-frequency region displayed a characteristic six-coordinate low-spin pattern, with
peaks at around 1,370 cm-1 (ν4), 1,496 cm-1 (ν3), and 1,583 cm-1 (ν2) (Fig. 3.6 B). The
L246K-3H showed almost identical six-coordinate features, indicating that it shared very
similar heme environment with L246K. The νFe-CO bands for both of them were both of
them were seen at 496 cm-1. Confirmation of these assignments was provided by the
observed shifts in the presence of 13C18O (Fig. 3.7 A). In addition, νC-O for L246K was at
approximately 1960 cm-1 in the 12C16O–13C18O difference spectrum (Fig. 3.7 B). Relating
the frequencies of νFe-CO and νC-O can provide valuable information about the proximal
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Figure 3.7 Fe2+-CO - Fe2+ -13C18O difference spectra P450camL246K in both low frequency
region (A) and high frequency region (B).

ligand identity and polarity of the distal environment of hemoprtoeins (61-63). Plots of
νFe-CO versus νC-O for a wide variety of heme-CO complexes are shown in Figure 3.8. The
observed 500 and 1960 cm-1 paring frequency for the CO complex of L246K mutant
placed it in the region of histidine proximal ligand and a hydrophobic distal environment
compared with myoglobin and peroxidases. Since the proximal histidine ligand has been
ruled out in the L246K mutant, the RR results of the CO complex could be indicative of a
protonated thiolate proximal ligation or an elongated iron-thiolate ligand.
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♥

Figure 3.8 Correlation of Fe–CO and C–O stretching frequencies for different heme proteins and
porphyrin derivatives. Lines 1 and 2 are for complexes in which the proximal ligand is thiolate
and histidine, respectively. The open circles, open squares, and open triangles correspond to data
are obtained for mutant and pH-variant forms of horseradish peroxidase (○), cytochrome c
peroxidase (□), and myoglobin (∆), respectively. The corresponding filled symbols represent data
are obtained from the wild-type proteins. The filled heart corresponds to P450L246K data
measured in this work. This figure is adapted from (61-63).

3.4.4 Catalytic activity of P450L246K
While it still remains challenging to distinguish between a protonated neutral thiol
and an elongated thiolate ligand in heme proteins that display abnormal spectroscopic
properties, it is generally agreed that the deprotonation of the proximal cysteine to
cysteinate that provides the necessary “push” effect throughout the reaction cycle is
indispensable for the catalytic activity of all known heme thiolate proteins.(1, 7-9, 47, 64)
Therefore, an activity assay should provide a convenient measure for the identification of
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Figure 3.9 Peroxidase activity of P450camL246K mutant, P420 and CPO determined by
monitoring the oxidation of ABTS at 405nm in the presence of H2O2 (3.3mM), ABTS (9.1mM),
and enzyme (2μM).

the nature of the proximal ligand in these proteins. Although both P420 and L246K
display essentially identical UV-vis spectral patterns, the proximal ligand to the heme
iron may not necessarily be the same. The fact that P420 is devoid of any catalytic
activity suggests a protonated cysteine as the proximal heme ligand in this inactivated
form of P450. However, the ABTS assay of L246K has shown that the mutant is able to
act as an efficient peroxygenase (Fig. 3.9), with comparable peroxidase activity with CPO,
via the peroxide shunt pathway. That implies that a deprotonated cysteinate ligates
weakly to the heme iron of the mutant with a lengthened Fe-S bond. The ability of
L246K to oxidize ABTS, a standard peroxidase substrate, in the presence of H2O2 alone
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strongly supports the importance of polarity of heme distal environment in regulating the
chemistry of heme proteins as predicted by structural comparison of CPO and P450cam.
In conclusion, our study shows that it is possible to engineer P450cam into a
self-sufficient biocatalyst by changing the polarity of the distal heme environment of the
protein. Our results provide strong evidence that the inactivated form of P450 (P420) uses
a protonated cysteine as its proximal heme iron ligand while L246K keeps the parent
protein’s thiolate ligand but with a longer Fe-S bond due to conformational changes
induced by the mutation. It is therefore concluded that proteins with identical spectral
signatures do not necessarily share the same heme environment.
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CHAPTER IV. SPECTROSCOPIC STUDY OF A NOVEL HEME IRON LIGAND
SET IN ENGINEERED CYTOCHROME P450CAM

4.1 SUMMARY
Substitution of glycine-248, the distal residue closest to the heme iron of
cytochrome P450cam, with a histidine leads to the formation of a mutant protein with a
novel Cys-Fe-His ligand set. This is one of the rarest cases of His ligation in
heme-thiolate proteins, and represents the first example observed for P450cam. The
G248H mutant shows very unique electronic absorption properties. The ferric form of
G248H displays a characteristic Soret band at 425 nm, while its ferrous-CO complex
shows the distinctive absorption maximum at approximately 450 nm indicative of the
intact Cys thiolate ligation. Surprisingly, this mutant does not bind any substrates or
exogenous ligands and is inert toward pH changes, suggesting the replacement of the
distal water molecule with the introduced His residue as the endogenous ligand.
Resonance Raman and circular dichroism spectroscopy results also support this model.
The spectrum of the ferric form of G248H displayed a six-coordinate low spin pattern.
The spectrum of ferrous mutant showed a mixture of six-coordinate low spin and
five-coordinate high spin, indicating that the distal His-Fe bond is weakened in the
ferrous form. The results have also provided evidence about the nature of proximal
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ligation of the P420 species, in which the nearby histidine is not a possible alternative for
the heme iron ligand.

4.2 INTRODUCTION
Cytochromes P450, a superfamily of heme b-containing monooxygenases
distributed in all domains of life, are involved in a wide range of physiologically and
biotechnologically significant transformations, including steroid synthesis, drug
metabolism, xenobiotic detoxification, and molecular signaling (1-4). The P450 enzymes
typically activate dioxygen and insert one oxygen atom into a wide variety of organic
substrates. The catalytic versatility makes these enzymes of great interest to the
biochemical and potentially industrial applications. The most distinctive structural feature
of cytochromes P450 is the coordination of a deprotonated cysteine to the heme iron as
the proximal ligand, while many other hemoproteins possess a histidine at the proximal
side. The strong electron-releasing character of the thiolate ligand has been reported to
serve as the “push” effect to facilitate the heterolytic O-O bond cleavage to generate the
activated intermediate Cpd I (iron-(IV)-oxo species) (5). With a few exceptions, the
diverse reactions catalyzed by P450s all requires an external source of reducing
equivalents like NAD(P)H and auxiliary proteins to transfer electrons to P450. The
requirement of expensive cofactors and the complication caused by additional proteins is
the limitation to the application of P450s as oxygenases. Some P450s are capable of
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accepting hydrogen peroxide or organic peroxy compound as an oxidant to catalyze
oxygen insertion through the so-called “peroxide-shunt” pathway in the absence of
electron transport proteins and the NAD(P)H cofactor (6-11). However, P450s are
typically not efficient in their utilization of hydrogen peroxide, the natural substrate for
peroxidases, as the source of oxygen atom in the monooxygenation reactions.
Cytochrome P450cam from Pseudomonus putida is one of the most well studied
members in the superfamily which catalyzes the region- and stereospecific hydroxylation
of its natural substrate d-camphor to 5-exo-hydroxy-camphor (12). A great deal of effort
has been made to suitably engineer this enzyme by directed evolution and active site
modification for the oxygenation of significant unnatural substrates. It is still quite
important to understand the roles of the active-site components in the reactivity, stability,
specificity and substrate recognition of this enzyme after its discovery for over 50 years.
To explore the possibility of converting the cytochrome P450cam into an efficient
self-sufficient heme peroxidase, we attempted to modify the heme distal side elements
which play crucial mechanistic roles and regulate the enzyme functions. In most heme
peroxidases, the distal histidine is highly conserved in the active site and has been
considered to serve as a general acid-base catalyst necessary for the formation of Cpd I
by donating a proton to the Fe3+-OOH moiety to promote the heterolytic cleavage of the
O-O bond in the peroxidase reaction cycles (13-16). It has been proposed that a
functional nitrogen (such as the nitrogen of His42 in HRP and His52 in CcP), located at a
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suitable distance from the heme iron, could behave as an acid-base catalyst in
hemoproteins (13, 17).
Therefore, in order to probe the roles of the nonpolar amino acids in the distal helix
and to make an efficient peroxygenase, we tried to substitute a distal residue with a
hydrophilic histidine. Given the proximity of the Gly248 residue to the heme group in
P450cam, it is a rational to choose this residue as the target for our purpose (Fig. 4.1).
The Gly248 residue, serving as a hydrogen bond partner with the side chain of Thr252
and resulting in an I-helix kink (18, 19), is conserved as a small residue (Gly or Ala) in
many P450s. In the previous study of P450 variants with the Gly or Ala substituted by a
carboxylate reside (Glu), the carboxylate group was reported to coordinate with the heme
iron, resulting in a six-coordinate ferric resting state in both P450cam and P450BM3
(20-22). Thus, Gly248 in P450cam has been chosen as a good candidate to explore the
consequences of functional alteration of the heme distal pocket on P450 structure and
catalysis. Surprisingly, the results of the G248H variant did not show any catalytic
activities at all because of the novel ligate set generated with the mutation. It is
demonstrated to contain a similar heme coordination with the P450BM3 A264H mutant
that was reported to possess a unique Cys-Fe-His heme ligand set (23). However, the
G248H mutant of P450cam was rather different from its parallel model in the P450BM3
variant, especially the heme coordination in its ferrous and ferrous-CO complexes. It is
shown for the first time that thiolate ligation remains intact without being displaced by
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Figure 4.1 The active site structure of camphor-bound cytochrome P450cam showing the
position of some important residues including G248. The figures were generated from the crystal
data (PDB code 2CPP) using PYMOL (18).
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another coordination group or deprotonated in various oxidation states either in modified
heme-thiolate proteins or in other hemoproteins with engineered proximal thiolate
ligation.
In this study various spectroscopic methods, such as electronic absorption,
resonance Raman, and circular dichroism have been applied to investigate the heme
coordination and ligation state of the heme active site in the G248H mutant. It has always
been difficult to identify a ligand trans to thiolate in the absence of structural detail, but
here we successfully presented sufficient spectroscopic results that identify axial ligand
trans to the cysteinate in this distinctive mutant of P450cam.

4.3 EXPERIMENTAL PROCEDURES
4.3.1 Site-directed Mutagenesis
Site-directed mutagenesis was performed by using this T7-based expression vector,
pET-30a (+). The G248H mutant of P450cam was prepared with the 5’-sense
oligonucleotide 5’- TTA CTG GTC CAT GGC CTG GAT ACG-3’ coding for
LLVHGLDT. The reconstituted plasmids of both wild type and G248H mutant were
transformed into E. coli strain NovaBlue and verified by DNA sequencing.
4.3.2 Protein Expression and Purification
The wild type P450cam and mutant G248H were expressed in Escherichia coli
strain Rosetta II (DE3). Cells were grown on terrific broth supplemented with 100mg/L
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of kanamycin at 37 ˚C and induced with 1mM IPTG and 1 mM camphor at OD600 around
0.8, followed by further growth at 30 °C for another 18 h prior to harvesting cells. As for
the mutant, the addition of δ-aminolevulinic acid to the growth media is necessitated to
facilitate holoenzyme production.
Cells were then lysed at 4 °C in 50 mM Tris-HCl buffer at pH 7.4 containing 50 mM
KCl, 0.5 mM DTT, 1 mM camphor (buffer A), 1 mM EDTA, 200 μM PMSF, 40 U/ml
Dnase I, 3 U/ml Rnase A, and lysozyme. Following sonication and centrifugation, the
lysed cells were concentrated by Amicon cell with 30,000 Da cut-off ultrafiltration
membrane. The protein solution was applied on a fast flow DEAE Sepharose column
(50ml) equilibrated with buffer A. After initial elution, the column was developed with a
linear 0-0.5 M KCl gradient in the same buffer. The red fractions containing the ~45 kDa
proteins were pooled for further purification by size exclusion chromatography. Sephadex
G-75 matrix (500 ml) was used for the gel filtration and the buffer applied was 100 mM
potassium phosphate buffer containing 1 mM camphor at pH 7.4. Substrate-free
WTP450cam and its mutant were prepared in the same way except for no camphor was
added during the expression and purification procedures. Unless otherwise specified, all
the steps in the protein purification were performed at 4 °C.
4.3.3 Spectroscopic characterization
Optical characterization of the wild type P450cam and its mutant was performed at
room temperature on a Cary 300 spectrophotometer (Varian). The ferrous proteins were
prepared by the addition of excess amount of sodium dithionite and CO adducts were
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obtained by CO gas bubbling. The buffer used for the absorption measurements was 100
mM potassium phosphate buffer with 1 mM camphor at pH 7.4.
CD spectra were measured on a JASCO J-815 spectrometer at room temperature.
The secondary-structure region (200-260 nm) of the spectra was recorded in a quartz
cuvette of 1mm path length using about 2 μM enzyme. As for the tertiary-structure region
(260-650 nm), they were recorded using about 20 μM enzyme in a quartz cuvette of 1 cm
path length with and without camphor.
For the resonance Raman data collection, the wild-type P450 and G248H mutant
samples (about 30 μM) were prepared in a septum-sealed, cylindrical quartz cell.
Samples were reduced to the ferrous form by first flushing the sample with argon and
then injecting a molar excess of buffered sodium dithionite solution. The rotating sample
cell was irradiated with 4 mW of 413.1 nm laser light using a mixed krypton/argon ion
laser (Spectra Physics, Beamlok 2060). The spectral acquisition time was 5 min. The
scattered light was collected at right angles to the incident beam and focused onto the
entrance slit (125 μm) of a 0.8 m spectrograph, where it was dispersed by a 600
groove/mm grating and detected by a liquid-N2-cooled CCD camera (Horiba-JY).
Spectral calibration was performed against the lines of mercury. UV-vis spectra of each
sample were collected before and after each RR measurement to ensure the sample
integrity.
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4.3.4 Redox potential measurements
The electrochemical measurements of the G248H mutant were performed with a
CHI 660 electrochemical analyzer (CH Instruments) at room temperature by using a
conventional three electrode cell, with a glassy carbon (GC) electrode as the working
electrode, platinum wire as counter electrode and Ag/AgCl electrode as the reference
electrode. The carbon electrode has been modified with single-walled carbon nanotubes
(SWCNT). The SWCNT modified electrode is electrochemically activated by cyclical
scanning between -1.0 and +1.5 V at a scan rate of 1 V/sec for 2 minutes to improve the
sensitivity of the electrode. The redox potentials of P450cam G248H mutant was
obtained and normalized with the reference to NHE.

4.4 RESULTS
4.4.1 Protein expression and purification
The G248H mutant of P450cam was expressed as a holoprotein with the facilitation of
heme precursor. The Rz values of pure wild-type P450cam and G248H mutant were both
over 1.4. The protein concentration was determined using the Soret extinction coefficient
determined by the pyridine hemochrome method following the standard protocol (24, 25).
The extinction coefficients for camphor-bound and camphor-free forms of the mutant
were found to be 113 and 125 mM-1cm-1, respectively, comparing with 102 and 115
mM-1cm-1 of the wild type protein.
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4.4.2 UV-vis spectroscopy
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Figure 4.2 UV-vis spectra of ferric, ferrous and ferrous-CO complexes of P450camG248H: (A)
camphor-free; (B) camphor-bound in 100mM phosphate buffer (pH7.4) at room temperature.
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The UV-vis spectra of wild type P450cam and G248H mutant were recorded in all
ferric, ferrous and ferrous carbon monoxide bound forms (Table 4.1). In contrast to the
substrate-free wild type protein in its oxidized state that has the Soret maximum at 417
nm, the G248H mutant exhibited a Soret band at 425 nm, red shifted by 8 nm (Fig. 4.2)
Notably, the ferric form of the mutant displayed an almost identical spectral pattern with
that of the wild type protein complexed with imidazole (26) and that of the P450BM3
A264H mutant (23), indicating that the substitution of the Gly248 with a histidine residue
similar to those proteins in these proteins. Furthermore, the UV-vis spectrum of ferric
P450camG248H did not show any change upon any ligand or substrate binding, and is
independent of pH change as well. However, the ferrous form of the mutant was quite
different from the wild type and its imidazole complex. Instead of showing the Soret
band at around 408nm upon reduction, the G248H mutant had its Soret band maximum at
421 nm. The ferrous-CO complex of the G248H mutant retained the characteristic Soret
band at around 450nm like the wild type P450cam, which suggested that despite the
introduction of a sterically larger group and also a stronger ligand, the thiolate ligation to
the heme iron in the proximal side was preserved.
Another distinct UV-vis spectral difference between the mutant and wild type lies in
the spectra of their camphor-bound forms. In wild type P450cam, the Soret band shifts
from 417 nm to 392 nm upon substrate binding, indicating the conversion of low-spin to
high-spin Fe (III). But the camphor binding was perturbed in the mutant since there was
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no detectable change in its camphor-bound form. Thus, in the presence of camphor, the
G248H mutant remained predominantly in the six-coordinate low-spin Fe (III) state.
Table 4.1 Wavelength and extinction coefficients of absorption maxima for wild type and G248H
mutant of cytochrome P450cam

Protein

Oxidation state

Soret (nm)

-band (nm)

Visible (nm)

Fe3+

418 (ε=115)

360

535, 569

Fe2+

408

540

Fe2+-CO

446

550

Fe3+

425 (ε=98)

Fe2+

409

543

Fe2+-CO

446

549

Fe3+

425 (ε=123)

Fe2+

421

541, 568

Fe2+-CO

446

545

Fe3+

424 (ε=122)

Fe2+

421

542, 569

Fe2+-CO

446

546

WTP450
(camphor-free)

360

541, 578

WTP450 +
Imidazole (26)

359

542, 573

G248H
(camphor-free)

359

542, 574

G248H
(camphor-bound)
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4.4.3 Resonance Raman Spectroscopy
To further examine its heme environment and the iron spin and ligation state, we
obtained RR spectra in various oxidation and coordination states of wild type and G248H
mutant in the absence and presence of substrate camphor. The RR spectrum of ferric
G248H with no camphor bound was very similar with to that of the wild type, displaying
a strong oxidation state marker band υ4 at around 1370 cm-1 that is typical of ferric (Fe3+)
heme (Fig. 4.3 A).

The heme core-size marker bands υ3 and υ2 appeared at proximately

1500 and 1580 cm-1, respectively for both camphor-free samples, indicating a
six-coordinate (6C), low-spin (LS) heme iron (27-29). However for the camphor-bound
proteins, the G248H mutant was markedly different from the wild type. The wild type
displayed the υ3 and υ2 bands at 1486 cm-1 and 1568 cm-1, respectively, typical of highspin, five-coordinate (5C), heme iron component. On the contrary, the camphor-bound
G248H was demonstrated to be a six-coordinate low-spin complex, as indicated by the
appearance of the υ3 and υ2 bands at 1500 and 1586 cm-1, almost identical to the camphorfree samples. This could be the result of an unusual axial ligation of the heme iron in the
G248H mutant.

118

A: Ferric

1532
1560
1578
1599

1427
1467

1584
1533
1562
1581
1600
1584

1360

1586
1622

1374

1500

G248H+cam

G248H+cam
1400

1423
1467

WT+cam

WT+cam

1200

1391
1424
1465

1344

G248H

1622

1369

1486
1568

1587
1624

1503

1374

G248H

1387
1422
1463

1358

WT
1366

WT

1580
1624

1500

1369

B: Ferrous

1200

1600

1400

1600
-1

-1

Raman Shift (cm )

Raman Shift (cm )

Figure 4.3 Resonance Raman spectra of (A) ferric and (B) ferrous wild-type P450 and
P450G248H mutant with and without camphor binding. The excitation wavelength (λex ) was
413.1nm. The spectra of P450 and G248H samples in the presence and absence of 1mM camphor
are shown.

In the ferrous form, the mutant also showed rather different spectral pattern from
that of the wild type in the absence and presence of camphor. The RR spectrum of the
camphor-free ferrous G248H had a significantly broadened υ4 band at 1366 cm-1 that
implied a six-coordinate complex and rather different from the wild type (Fig. 4.3 B).
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Figure 4.4 Resonance Raman spectra of ferrous-CO complexes of wild-type P450 and
P450G248H mutant with and without camphor binding in both low frequency (A) and high
frequency (B). The excitation wavelength (λex) was 413.1nm. The spectra of P450 and G248H
samples in the presence and absence of 1mM camphor are shown.

Typically the υ4 band appears slightly higher (~1370 cm-1) for six-coordinate ferrous
complexes (e.g., CO and NO complexes), which suggested that in the case of G248H the
sixth ligand was bonded rather weakly to the heme iron. Consistent with this, a very weak
shoulder on the low frequency edge of the υ4 band could be seen in the G248H RR
spectrum that was the result of a small population of the five-coordinate thiolate complex.
Compared with the camphor free protein, the camphor-bound mutant demonstrated a
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similar spectral pattern except for the υ4 band which shifted from 1366cm-1 to 1360cm-1,
possibly due to the interference of camphor in the His binding to the heme iron in some
way.
Assignment of the Fe–CO and C–O stretching modes of the FeII–CO complexes is
useful because they are influenced by the nature of proximal ligand (30, 31). The RR
spectra of the FeII–CO complexes of the wild type and G248H mutant in the
high-frequency region displayed a characteristic six-coordinate low-spin pattern, with
peaks at about 1368 cm-1 (ν4), 1495 cm-1 (ν3), and 1580 cm-1 (ν2), respectively (Fig. 4.4
B). The νFe-CO bands showed some difference between the camphor-free and
camphor-bound proteins. Especially for G248H with camphor, the CO stretch at around
500 cm-1 was missing which was possibly due to the preventive interference of the His
ligand in the distal site, suggesting CO could only partially bind to the ferrous heme iron
and there was still some portion of histidine ligated to the iron.
4.4.4 Circular dichroism spectroscopy
To investigate the effect of the mutation on the conformational change of the protein,
multi-wavelength CD studies of the wild type and G248H mutant of P450cam were
carried out. The far-UV CD spectra (190-260 nm) for both substrate-free and
substrate-bound forms of G248H mutant heme domain exhibited no obvious change
compared with that of the wild type, with minima at 219 and 209 nm respectively,
indicating the secondary structure was not significantly altered by the substitution of
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G248 with a histidine. Neither did the addition of camphor have any effect on the
secondary structure of the protein in the predominantly α-helical heme domain.
However, in the near-UV-visible CD region (300-650 nm), the G248H mutant
showed rather different spectra in its resting ferric form from that of the wild type.
Furthemore, the substrate free and substrate bound forms of the mutant were markedly
distinct from each other. In the absence of camphor, the Soret and δ bands in the heme
CD spectrum of wild type P450cam appeared at 410 and 353 nm in negative ellipticity
(Fig. 4.5A). The Soret band shifted to 388nm upon substrate binding, with the δ band
disappearing (Fig. 4.5 B). Thus, the blue shift of the Soret band of P450cam mimicked
the optical transition in the UV-vis spectrum to some extent. However, the
near-UV-visible CD spectrum of the substrate-free G248H heme domain has its Soret
band at 423 nm and the addition of substrate camphor triggered dramatic change in the
Soret band, resulting in split peaks at 405 and 436 nm, respectively. This feature of the
substrate-bound G248H mutant was more significantly different than that of the optical
absorption spectra.
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Figure 4.5 CD spectra of both substrate-free (A) and substrate-bound (B) forms of the WT and
G248H mutant of cytochrome P450cam.
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4.4.5 Electrochemical study
Derived from Figure 4.6, the redox potential for G248H mutant was measured to be
about -92 mV, compared with -135 mV for wild type. There was some positive shift of
the Fe3+/Fe2+ redox couple caused by the substitution of the distal glycine with a histidine
residue. The redox potential change could be the result of the introduction of histidine
into the distal heme pocket which increased the total charge near the heme group and
made it easier to be reduced.
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Figure 4.6 Cyclic voltammograms of P450cam and P450camG248H on a glass carbon electrode
modified with SWNTs. Voltammograms were recorded between -1.0 and +1.5V at the scan rate of
1V/sec in 100mM phosphate buffer (pH7.4).
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4.5 DISCUSSION AND CONCLUSION
This work has demonstrated an intriguing model of heme-thiolate protein with a
histidine serving as the 6th axial ligand at the distal side of the heme group. Up to date,
there are several proteins reported to possess such Cys-His coordination. In nature, this
ligand set has only been seen in cystathionine β-synthase (32) and Rhodovulum
sulfidophilum SoxAX enzyme (33). Also, a few hemoproteins have been engineered to
introduce the distal histidine ligation or proximal cysteinate ligation in the heme pocket,
such as the M80C variant of cytochrome c (34), A264H variant of cytochrome P450BM3
(23), and H39C mutant of cytochrome b5 (35). But in all these cases, the proximal
cysteinate ligation was only observed in the ferric but not the ferrous oxidation state.
Upon reduction the proximal thiolate is either protonated or replaced by an alternative
coordinating group except for the P450BM3 A264H mutant which was not even able to
be completely reduced and form any significant amount of CO complex. We have
presented here the first example of hemoprotein with a Cys-Fe-His ligand set which is
preserved in various oxidation states.
In the electronic absorption spectroscopic studies, the UV-visible spectra of the
G248H mutant of P450cam displayed features that are typical of six-coordinate, low-spin
heme complexes in the absence of substrate. The Soret band of the camphor-free mutant
was shown red shifted from 417 nm to 425 nm, similar to what was observed in the
imidazole-coordinated wild type protein and cytochrome P450BM3 A264H mutant,
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indicating the heme iron ligation is complete with distal water ligand replaced by
histidine, a stronger field ligand. Interestingly the significant spin and coordination state
changes that occur in wild type P450cam upon camphor binding were not observed in the
mutant, and the UV spectra of G248H mutant in the absence and presence of camphor
were virtually indistinguishable. This implied the substrate binding was perturbed in the
variant, and camphor was not able to displace the axial heme ligand and alter the heme
environment in the case of the wild type protein. Because of the complete axial ligation,
it made the mutant unable to bind any ligands. This was confirmed by the resonance
Raman spectroscopic spectra in which the ferric G248H variant showed LS, 6C with His
and Cys as the distal and proximal ligand respectively, regardless of whether the substrate
camphor is bound or not.
Comparing the ferrous form of the imidazole complex of wild type, the G248H
mutant was different not only in its Soret band maximum but also in the Q band region.
The mutant displayed two α and β bands in the ferrous form, which was strong evidence
of six coordination of the heme iron. However as for the imidazole complex of wild type
protein, it showed only one band like the wild type and many other hemoproteins,
indicating the preference of a five-coordination heme upon reduction. Intriguingly, in the
study of the P450BM3 A264H mutant, a parallel variant of G248H, the distal ligand
remained firmly bound on reduction and CO was not able to displace the His264 ligand.
In G248H mutant, its CO complex exhibited the characteristic Soret band at around
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450nm as the wild type, strongly indicating the preserved thiolate ligation in its ferrous
form. Also, the RR spectra displayed distinct features of the mutant in its ferrous and CO
complexes. The υ4 band of the ferrous G248H shifted to 1366 and 1360 cm-1, respectively
for the substrate-free and substrate-bound forms, which were not in the region of either
5C cysteine proximal ligation (1340-1348 cm-1) or 5C histidine proximal ligation
(1350-1358 cm-1) (36, 37). This suggests that upon reduction, part of the histidine ligand
was lost, resulting in a mixture of 5C and 6C coordination. Once CO was introduced, CO
could partially bind to ferrous heme iron, but not dominantly.
According to the far-UV CD spectra, the secondary structure of the protein was not
affected by the substitution of G248 with a histidine. However, there were indeed distinct
changes in the tertiary structure around the heme pocket in the mutant compared with that
of the wild type. The CD spectra showed markedly in different pattern in the presence
and absence of camphor, especially in the substrate-bound form, which implied more
significant conformational change. Except for the shift of Soret band, a set of split peaks
was observed, indicative of strong six-coordinate ligation. Thus the binding of camphor
makes the distal pocket more compact like the wild type and results in a stronger
histidine ligation to the heme iron.
Taken together, the data of the various spectroscopic studies have demonstrated that
the substitution of G248 with a histidine induces conformational change in the active site,
yeilding a histidine ligation to the heme iron and alteration of the access of the substrate
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camphor to the heme prosthetic group. When the variant is reduced and CO is introduced,
the proximal thiolate ligation remained intact while part of the distal histidine was
displaced. This is quite different from other reported proteins with such Cys-Fe-His
ligation set, whether it is naturally occurring or exogenously introduced. The thiolate
ligand tends to be lost by protonation or displaced by another coordination group in the
reduced form. This phenomenon has also been reported in many other hemoproteins with
thiolate ligation in their ferric forms such as CO-sensing CooA protein (38), H93C
mutant of myoglobin (Mb) (39), H175C mutant of cytochrome c peroxidase (40) and
inactive forms of cytochrome P450 (P420) and chloroperoxidase (C420) (41, 42). Except
for CooA, which has been reported that the proximal ferrous ligand switches from Cys75
to His77, other hemoproteins has been proposed to use neutral cysteine thiol as the
possible ligand (43) or the proximal cysteinate ligand could be replaced by a nearby
histidine residue.
For instance, in the study of heme iron coordination of C420, it was suggested that
ferric C420 appeared to retain a thiolate proximal ligand but not in its ferrous form with
the distal histidine serving as a potential ligand to the heme iron. It has also been
proposed in the probe of ferrous P420 that histidine ligation might be involved. All the
hypotheses imply that histidine serves as an axial ligand to heme iron more readily than
cysteinate in the hemoproteins. However, our results failed to support these hypotheses.
Our study unequivocally demonstrated that the endogenous thiolate ligand is retained in
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all oxidation states in our G248H mutant. It is evident that with both His and Cys ligated
to the heme iron at the ferric state, it is the His rather than the Cys that would fall of up
reduction and CO binding, suggesting the cysteinate ligation is more stable in this case,
i.e. the iron-sulfur bond is stronger than the iron-nitrogen bond.
The crystal structural study of wild type P450cam complexed with imidazole has
shown that the imidazole group was bound perpendicular to the plane of the heme (44).
In the P450BM3 variant A264H, the angle between the plane of heme and imidazole ring
of His-264 is almost exactly 90° and the imidazole is orientated at about 45° to the
pyrrole nitrogens to minimize unfavorable interactions.(23) Therefore, we propose here
that in the P450cam G248H mutant, the binding of the hisitidine ligand involves
coordination of the imidazole group to the heme iron in a similar way to the two models
mentioned above.
We conclude from the data presented in this work that the P450cam G248H mutant
is the first model of complete axial coordination with cysteinate and histidine serving as
the ligands to the heme iron, in which the thiolate ligation remains intact upon reduction
and CO binding. We also propose that for hemoproteins with endogenous cysteine
ligation, the thiolate ligand would not be easily displaced by another ligand provided by
nearby residues or solvent and that cysteine serves as a stronger ligand than histidine. The
study of this “locking” heme model could lead to the promising development of a
diagnostic spectroscopic method for thiolate-ligated hemoproteins to recognize such
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coordination when it occurs elsewhere in nature or in other pertinent engineered protein
systems.
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CHAPTER V. PROTEIN ENGINEERING OF MYOGLOBIN WITH THIOLATE
PROXIMAL LIGATION

5.1 SUMMARY
Myoglobin has been used as a model in the investigations of protein folding, ligand
binding and conformational transitions of heme-containing proteins. Many studies of
heme-imidazole proteins including myoglobin have been carried out to replace the
proximal axial histidine ligand with a cysteine residue to gain the heme-thiolate protein
structural character. Although some of the protein variants achieved the iron-thiolate
ligation in their ferric forms, the iron-thiolate ligand failed to retain upon reduction.
Therefore, to explore the possibility of converting myoglobin to a heme-thiolate protein
in all oxidation states, I tried to mimic the protein environment of both cytochrome
P450cam and chloroperoxidase respectively in the proximal side of sperm whale
myoglobin by replacing eight amino acids around the iron-histidine ligand. UV-visible
spectroscopic studies were performed to examine the axial ligation in the wild type and
mutant proteins of Mb. Neither the P450 mimic nor the CPO mimic showed the
characteristic Soret absorption maxima around 450nm when reduced in the presence of
carbon monoxide, suggesting the thiolate ligation was not reserved in the ferrous forms.
Considering the possible interference of distal histidine as a competitive candidate ligand
to the heme iron, the His64 was substituted with an alanine and glutamic acid based on
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comparisons with the structure of P450 and CPO, respectively. The optical spectral
properties showed no difference. It happened again in the further mutation by replacing
the His 97 which is located in the proximal vicinity with an alanine.

5.2 INTRODUCTION
Myoglobin is a monomeric heme protein found mainly in muscle tissues where it
acts as an intracellular primary storage site for oxygen by reversibly binding oxygen
molecules (1). This protein has been the target of extensive biochemical and biophysical
studies for many years because of its physiological importance, availability and
simplicity compared with other bulky heme proteins. It serves as a prototype for
elucidating the roles of critical active site residues in the interactions of hemoproteins
with small molecules such as dioxygen, carbon monoxide, and cyanide (2-5). In
myoglobin, there is a conserved histidine residue (His93) serving as the proximal axial
ligand to the heme iron, anchoring the heme group in the globin, and a conserved
hisitidine residue (His64) in the distal pocket, conferring a large measure of specificity
for O2 (6). Both of these histidine residues are important in terms of protein structure and
function. Quite a few studies have been dedicated to examine their roles in the active site
of myoglobins from various sources by site-directed mutagenesis in the last few decades
(7-11).
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Cysteine plays a key role as a metal ligand in metalloproteins, especially in
heme-containing proteins. A distinctive feature of heme-thiolate proteins is a Soret
absorption band at around 450 nm in the CO difference spectrum of the reduced forms.
The anionic cysteinate that coordinates to the heme iron in heme-thiolate proteins has
been claimed to serve as a strong electron donor to facilitate the heterolytic O-O bond
cleavage and the formation of Cpd I, the highly active reaction intermediate responsible
for the catalytic reactions (12, 13). To clarify the critical role of the anionic axial ligands
of heme proteins on the O-O bond scission reaction and the contributions of proximal
Cys ligation to the functional and catalytic properties of cytochrome P450 and CPO, the
proximal histidine 93 of human myglobins and horse heart myoglobin has been replaced
with a cysteine residue (9, 10). The Mb H93C mutants resulted in altered axial ligations
analogous to those of P-450 or CPO. The cysteine coordination to the ferric heme iron is
confirmed by various biophysical methods, with the mutants showing almost identical
spectroscopic properties to those of heme-thiolate proteins. The Mb H93C mutants were
revealed to be in the ferric high-spin, five-coordinate state with the proximal cysteine
ligated to the heme iron (9). Therefore, it is proved that the axial ligand of the heme iron
is responsible for the spectroscopic features of hemoproteins, which has been indicated
by various hemoproteins and their ligand-bound complexes.
For catalytic activities, the cysteine must be deprotonated to cysteinate throughout
the reaction cycle as the iron changes oxidation state from ferric to ferrous and ferryl
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states. The role of the anionic axial ligands on the O-O bond cleavage is examined by
reactions utilizing peroxides. The results of Mb H93C mutants showed that the thiolate
ligand enhanced the heterolytic O-O bond scission of the oxidant. This mutant also
displayed about a 5-fold increase in epoxidation activity (9). Although the ferric forms of
the mutants showed iron-cysteine ligation, upon reduction of the H93C variants with
sodium dithionite under a CO atmosphere, the CO complexes displayed a similar
spectrum to that of wild type Mb, the typical heme-imidazole protein, with the Soret band
at around 420 nm instead of 450 nm. Thus, it is unlikely that the cysteine thiolate remains
as the proximal ligand to the ferrous heme iron. The spectroscopic study of the mutants
confirms that in Mb H93C the distal histidine is coordinated to the heme iron, despite the
suggestion of a neutral thiol serving as the proximal ligand upon reduction (10, 14). On
the basis of the H93C single mutant, several studies have been carried out to replace the
distal histidine with a glycine, valine or isoleucine as well. The ferric state of these
variants closely resembled the spectroscopic properties of the corresponding ferric
cytochrome P450. However, the ferrous and ferrous-CO complexes of these variants
remained virtually the same as for the H93C single mutant. According to these results, it
is apparent that while simple mutagenesis modifications of the Mb active site can mimic
the characteristics of ferric cytochrome P450 or CPO, the reproduction of the
spectroscopic properties of their ferrous forms would require more subtle modifications
though, which is the ultimate goal of this study.
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Sperm whale myoglobin (Mb), a single-chain globin protein of 154 amino acids has
been chosen because it reprents one of the most extensively studied heme-containing
proteins by biochemical, biophysical and spectroscopic techniques. It was the first protein
whose crystal structure was determined to high resolution by x-ray crystallographic
analysis in 1960 (15). Sperm whale myoglobin is composed of eight α helices (labeled
A-H in Fig. 5.1) that form an amphipathic pocket with the heme prosthetic group bound
between the helices. The heme iron is coordinated to the protein via a histidine ligand
located in the F helix at the proximal site. The majority of other heme-protein contacts
are hydrophobic except for the two solvent- exposed propionate side chains of the heme
group that interact electrostatically with the protein residues around the prosthetic group.
Figure 5.2 illustrates the active site structure of sperm whale myoglobin with
histidine residues in both proximal and distal sides along with several important amino
acids in the proximal helix F from Leu89 to His97, with His 93 in the middle. To
engineer sperm whale myoglobin into a heme-thiolate protein model in various oxidation
states, all eight proximal residues around the axial ligand were replaced by the
corresponding amino acids in P450cam and CPO, resulting in the P450 mimic of Mb
(MbP) and CPO mimic of Mb (MbO). Furthermore, the distal histidine was substituted
with an alanine and glutamic acid, respectively, for MbP and MbO. Finally, as the distal
H97 that could be a potential competitive ligand to the heme iron in the ferrous forms of
the Mb variants was also replaced. UV-visible spectroscopic studies have been carried out
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to examine the optical properties and structural characteristics of the generated mutants of
sperm whale myoglobin.

D
B

C

G

E

A

H
F

Figure 5.1 A ribbon diagram of the sperm whale myoglobin crystal structure showing the
arrangement of eight α helices and the heme group (shown in yellow). This figure was generated
from the crystal data (PDB code 1VXH) using PYMOL (6).
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Figure 5.2 Crystal structure of sperm whale myglobin active site with some important amino
acids around heme group (yellow) viewed from different angles. In (B) the proximal amino acids
were colored in rainbow. The figures were generated from the crystal data (PDB code 1VXH)
using PYMOL (1).
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5.3 EXPERIMENTAL PROCEDURES
5.3.1 Bacterial strains, plasmids and DNA manipulations
The bacterial strains used were E. coli NovaBlue and E. coli Rosetta II (DE3) from
Novagen (Gibbstown, NJ). The used plasmid pMb122 containing wild type sperm whale
myoglobin gene in a pUC19 vector is identical to pMb413a used by Springer et al. except
for a correction in the coding sequence (N122D) due to a mistake in the original sequence
(16). To increase the protein yield, the Mb gene was constructed into a T7-based
expression vector, pET-30a (+) from Novagen, at the sites of NdeI and KpNI by
polymerase chain reactions and ligation reactions. Bacteria were grown in Luria-broth
supplemented with antibiotic (kanamycin 100 μg/ml) for DNA manipulation.
5.3.3 Site-directed mutagenesis and protein expression.
Table 5.1 Proximal sequence alignment of Mb and its P450 and CPO mimics

Protein

Proximal sequence

WT Mb

L

A

Q

S

H93

A

T

K

MbP (P450 mimic)

G

S

R

L

C93

L

G

Q

MbO (CPO mimic)

S

R

A

P

C93

P

A

L

The proximal sequence alignment of sperm whale Mb and its P450 and CPO mimics
is listed in Table 5.1. The MbP mutant was prepared with the 5’-sense oligonucleotide 5’GGT TCT CGT CTG TGC CTG GGT CAG CAT AAG ATC CCG ATC AA coding for

GSRLCLGQHKIPI (P450mimic). The MbO mutant was obtained with the 5’-sense
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oligonucleotide 5’- TCT CGT GCT CCT TGC CCA GCT CTG CAT AAG ATC CCG
ATC AA coding for SRAPCPALHKIPI. Primers used for all other Mb variants are listed
in appendix C. The reconstituted plasmids containing Mb and the mutants were
transformed into E. coli strain NovaBlue and verified by DNA sequencing (Macrogen,
MD). Proteins were expressed in E. coli strain Rosetta II (DE3). Cells were grown on
Luria broth supplemented with 100 mg/L of kanamycin at 37 ˚C and induced with 1mM
IPTG when OD600 reashes around 1.2, followed by further growth for 4 hours prior to
harvest. As for the mutants, the addition of δ-aminolevulinic acid to the growth media is
necessitated to facilitate holoenzyme production. The cells were then harvested and
frozen at -80 °C.
5.3.4 Protein purification
Cells were lysed at 4°C in 25 mM Tris-HCl buffer at pH 8.0 containing 0.5 mM
DTT, 1 mM EDTA, 200 μM PMSF, 40 U/ml Dnase I, 3 U/ml Rnase A, and lysozyme for
overnight in a shaker. After freezing at -80°C for the second time, the cells were thawed
again followed by centrifugation and concentration using an Amicon cell with 10,000 Da
cut-off ultrafiltration membrane. The protein solution was first applied on a fast flow
DEAE Sepharose column equilibrated with the 10mM Tris-HCl buffer at pH 8.2. After
initial wash, proteins were eluted with a linear 0-0.5 M NaCl gradient in the same buffer.
All Mb mutants were expressed as apo-proteins and converted to holoproteins via heme
reconstitution. Typically, hemin was added to the apo-protein drop wise which was
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mixing on a stirrer for overnight (17). After heme reconstitution, the protein sample was
again applied onto a fast flow DEAE Sepharose column. The reddish fractions of correct
molecular weight were pooled and concentrated using a Centriprep with an YM10
membrane for further purification by size exclusion chromatography. The buffer used for
gel filtration was 0.1 M potassium phosphate buffer at pH 7.0. Unless otherwise specified,
all steps in the protein purification procedure were performed at 4 °C.
5.3.5 Electronic absorption spectroscopy
The UV-visible spectra of the Mb and its mutants were recorded on a Varian Cary
300 Bio UV-visible spectrophotometer at room temperature. The ferrous proteins were
prepared by the addition of excess amount of sodium dithionite and CO adducts were
obtained by CO gas bubbling. The buffer used for the absorption measurements was 100
mM potassium phosphate buffer at pH 7.0.

5.4 RESULTS AND DISCUSSION
There are two major groups of hemoprotein found in living organisms, namely
“heme-thiolate proteins” and “heme-imidazole proteins”. The difference between these
two classes of proteins is that when carbon monoxide binds to the reduced forms,
heme-thiolate proteins usually give a characteristic optical absorption spectrum with a
prominent Soret peak at around 450 nm, whereas the corresponding absorption spectrum
of heme-imidazolate proteins shows a Soret peak at around 420 nm. This work intended
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Figure 5.3. UV-visible spectra of wild type Mb (A), P450cam (B) and CPO (C) in various
oxidation states
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to investigate the role of proximal ligands in heme-thiolate proteins by changing the
amino acids at the proximal side of sperm whale myoglobin, a typical heme-imidazole
protein, to that of P450 or CPO.
First of all, wild type myoglobin, cytochrome P450cam and CPO were expressed
and purified according to reported procedures (18-20). Figure 5.3 showed the UV-vis
spectroscopic results of these proteins. In agreement with the literature, the ferrous-CO
complexes of Mb displayed Soret absorption maximum at 420 nm, while P450cam and
CPO exhibited the Soret band at 450 nm. By changing the proximal helix residues to
mimic those of P450 and CPO, the resulted mutants were expected to show spectral
properties similar to such heme-thiolate proteins.
5.4.1. Mb mutant: MbP/MbO
Eight amino acids, at the heme proximal side of sperm whale Mb, including His 93
have been replaced to mimic the protein environment of cytochrome P450cam and CPO,
respectively. The mutants were named MbP and MbO. The primers were designed as one
containing all the mutations at the end and the other one having the gene sequence at the
opposite direction. The PCR and self-ligation reactions were performed which directly
produced the mutated recombinant plasmid with the facilitation of T4 polynucleotide
kinase. Both of the mutants were over expressed in E. coli. Since they showed quite
similar results, only the electronic absorption spectra of the P450 mimic were included.
As shown in Fig. 5.4, the UV-vis spectra of Mb exhibited very similar results with those
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of wild type Mb with the Soret band of the ferrous heme-CO complex at 420nm, instead
of 450nm expected for Fe-thiolate ligation. This indicated that the thiolate sulfur might
not be ligated to the heme iron upon reduction and CO binding. There could be other
possible factors governing the spectral properties of the mutant, for instance the influence
of the distal histidine. Therefore, the distal histidine was replaced by a glycine and
glutamic acid in the P450 and CPO mimics, respectively.
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Figure 5.4 UV-visible spectra of MbP in various oxidation states.
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5.4.2. Mb mutant: MbP H64G/MbO H64E
To investigate the possible interference of the distal histidine, MbP H64G and MbO
H64E mutants were obtained. Fig. 5.5 shows the UV-vis results of the MbP H64G mutant.
Unexpectedly, the Soret peak of the ferrous-CO complex of this Mb mutant remained at
around 420 nm (Table 5.2). Thus, further modifications are needed to achieve a thiolate
proximal ligand in the Mb variant at reduced state.
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Figure 5.5 UV-visible spectra of MbP H64G in various oxidation states.
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Table 5.2 Wavelength and extinction coefficients of absorption maxima for P450cam, Mb,
MbP, and MbP H64G.

Protein
P450cam

CPO

Mb

Oxidation state

Soret band (nm)

Visible bands (nm)

Fe3+

392 (ε=102) (21)

535, 569

Fe2+

408

540

Fe2+-CO

446

550

Fe3+

398 (ε=91.2) (22)

516, 550, 650

Fe2+

408

550

Fe2+-CO

445

550

Fe3+

408 (ε=184) (11)

502, 631

2+

433

556

2+-

422

541, 578

Fe

3+

407

534, 569

Fe

2+

425

532, 559

2+-

Fe CO

421

533, 561, 619

Fe3+

407

537, 576

Fe2+

425

533, 561

Fe2+-CO

422

538, 568, 620

Fe

Fe CO
MbP

MbP H64G

5.4.3. Mb mutant: MbP H64G H97A/MbO H64E H97A
Considering that the proximal histidine 97 is located in the helix F closely to the
heme iron and the iron-histidine ligand (His93) (Fig. 5.2), it could be a possible
competitor to interference the altered thiolate ligation in the proximal side of MbP H64G
mutant. Therefore, it was replaced by an alanine, which is a good helix promoter, for both
the P450 and CPO mimics. Unfortunately, the UV-vis results showed nothing different
from the MbP H64G mutant (data not shown). In conclusion, the attempt to engineer
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myoglobin with a proximal thiolate ligand that can be retained in all oxidation states to
achieve a P450-like variant was not successful. This difficulty was also reported by
several previous studies, in which the proximal histidine was replaced by a cysteine but
the thiolate ligation was lost upon reduction (23-26). It is apparent that the heme-thiolate
proteins and heme-imidazole proteins have distinct structural and functional differences
and it would take more than just mimicking the active site residues to convert one to
another.
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APPENDIX A
Sequences of P450cam and pET-30a (+) Vector
General information
The cytochrome P450cam protein includes 414 amino acids.
Figure A.1 lists the amino acid sequence of full-length, wild-type cytochrome P450cam.
Figure A.2 lists the complete nucleotide sequence of the 1578-bp PstI-Hind111 fragment,
including the wild-type cytochrome P450cam structural gene from Pseudomonas putida,
155 bp of 5' flanking sequence, and 175 bp of 3' DNA.
Figure A.3 lists the nucleotide sequence of vector pET-30a (+) from Novagen.
Figure A.4 displays a map of plasmid pET-30a (+)_P450cam, which is the pET-30a (+)
vector with the P450cam gene cloned in.
Figure A.5 lists the nucleotide sequence of plasmid pET-30a (+)_P450cam containing
vector pET-30a(+) and wild-type cytochrome P450cam gene cloned into NdeI (5’-end,
nucleotide position 1596 in the pET-30a (+) vector sequence) and HindIII (3’-end,
nucleotide position 173 in the pET-30a (+) vector sequence). The numbering is
correspondent to that of Figure A.5.
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Figure A.1 Amino acid sequence of full-length of WT cytochrome P450cam.
1 MTTETIQSNA NLAPLPPHVP EHLVFDFDMY NPSNLSAGVQ EAWAVLQESN
51 VPDLVWTRCN GGHWIATRGQ LIREAYEDYR HFSSECPFIP REAGEAYDFI
101 PTSMDPPEQR QFRALANQVV GMPVVDKLEN RIQELACSLI ESLRPQGQCN
151 FTEDYAEPFP IRIFMLLAGL PEEDIPHLKY LTDQMTRPDG SMTFAEAKEA
201 LYDYLIPIIE QRRQKPGTDA ISIVANGQVN GRPITSDEAK RMCGLLLVGG
251 LDTVVNFLSF SMEFLAKSPE HRQELIERPE RIPAACEELL RRFSLVADGR
301 ILTSDYEFHG VQLKKGDQIL LPQMLSGLDE RENACPMHVD FSRQKVSHTT
351 FGHGSHLCLG QHLARREIIV TLKEWLTRIP DFSIAPGAQI QHKSGIVSGV
401 QALPLVWDPA TTKAV
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Figure A.2 Nucleotide sequence of full-length WT cytochrome P450cam from
Pseudomonas putida (5 bp upstream of PstI site, total 1578bp).
1 CTGCAGGATC GTTATCCGCT GGCCGATCTG ATCACCCAGC GTTTTTCCAT
51 CGACGAGGCC AGCAAGGCAC TTGAACTGGT CAAGGCAGGA GCACTGATCA
101 AACCCGTGAT CGACTCCACT CTTTAGCCAA CCCGCGTTCC AGGAGAACAA
151 CAACAATGAC GACTGAAACC ATACAAAGCA ACGCCAATCT TGCCCCTCTG
201 CCACCCCATG TGCCAGAGCA CCTGGTATTC GACTTCGACA TGTACAATCC
251 GTCGAATCTG TCTGCCGGCG TGCAGGAGGC CTGGGCAGTT CTGCAAGAAT
301 CAAACGTACC GGATCTGGTG TGGACTCGCT GCAACGGCGG ACACTGGATC
351 GCCACTCGCG GCCAACTGAT CCGTGAGGCC TATGAAGATT ACCGCCACTT
401 TTCCAGCGAG TGCCCGTTCA TCCCTCGTGA AGCCGGCGAA GCCTACGACT
451 TCATTCCCAC CTCGATGGAT CCGCCCGAGC AGCGCCAGTT TCGTGCGCTG
501 GCCAACCAAG TGGTTGGCAT GCCGGTGGTG GATAAGCTGG AGAACCGGAT
551 CCAGGAGCTG GCCTGCTCGC TGATCGAGAG CCTGCGCCCG CAAGGACAGT
601 GCAACTTCAC CGAGGACTAC GCCGAACCCT TCCCGATACG CATCTTCATG
651 CTGCTCGCAG GTCTACCGGA AGAAGATATC CCGCACTTGA AATACCTAAC
701 GGATCAGATG ACCCGTCCGG ATGGCAGCAT GACCTTCGCA GAGGCCAAGG
751 AGGCGCTCTA CGACTATCTG ATACCGATCA TCGAGCAACG CAGGCAGAAG
801 CCGGGAACCG ACGCTATCAG CATCGTTGCC AACGGCCAGG TCAATGGGCG
851 ACCGATCACC AGTGACGAAG CCAAGAGGAT GTGTGGCCTG TTACTGGTCG
901 GCGGCCTGGA TACGGTGGTC AATTTCCTCA GCTTCAGCAT GGAGTTCCTG
951 GCCAAAAGCC CGGAGCATCG CCAGGAGCTG ATCGAGCGTC CCGAGCGTAT
1001 TCCAGCCGCT TGCGAGGAAC TACTCCGGCG CTTCTCGCTG GTTGCCGATG
1051 GCCGCATCCT CACCTCCGAT TACGAGTTTC ATGGCGTGCA ACTGAAGAAA
1101 GGTGACCAGA TCCTGCTACC GCAGATGCTG TCTGGCCTGG ATGAGCGCGA
1151 AAACGCCTGC CCGATGCACG TCGACTTCAG TCGCCAAAAG GTTTCACACA
1201 CCACCTTTGG CCACGGCAGC CATCTGTGCC TTGGCCAGCA CCTGGCCCGC
1251 CGGGAAATCA TCGTCACCCT CAAGGAATGG CTGACCAGGA TTCCTGACTT
1301 CTCCATTGCC CCGGGTGCCC AGATTCAGCA CAAGAGCGGC ATCGTCAGCG
1351 GCGTGCAGGC ACTCCCTCTG GTCTGGGATC CGGCGACTAC CAAAGCGGTA
1401 TAAACACATG GGAGTGCGTG CTAAGTGAAC GCAAACGACA ACGTGGTCAT
1451 CGTCGGTACC GGACTGGCTG GCGTTGAGGT CGCCTTCGGC CTGCGCGCCA
1501 GCGGCTGGGA AGGCAATATC CGGTTGGTGG GGGATGCGAC GGTAATTCCC
1551 CATCACCTAC CACCGCTATC CAAAGCTT
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Figure A.3 Nucleotide sequence of vector pET-30a (+).
1 ATCCGGATAT AGTTCCTCCT TTCAGCAAAA AACCCCTCAA GACCCGTTTA
51 GAGGCCCCAA GGGGTTATGC TAGTTATTGC TCAGCGGTGG CAGCAGCCAA
101 CTCAGCTTCC TTTCGGGCTT TGTTAGCAGC CGGATCTCAG TGGTGGTGGT
151 GGTGGTGCTC GAGTGCGGCC GCAAGCTTGT CGACGGAGCT CGAATTCGGA
201 TCCGATATCA GCCATGGCCT TGTCGTCGTC GTCGGTACCC AGATCTGGGC
251 TGTCCATGTG CTGGCGTTCG AATTTAGCAG CAGCGGTTTC TTTCATACCA
301 GAACCGCGTG GCACCAGACC AGAAGAATGA TGATGATGAT GGTGCATATG
351 TATATCTCCT TCTTAAAGTT AAACAAAATT ATTTCTAGAG GGGAATTGTT
401 ATCCGCTCAC AATTCCCCTA TAGTGAGTCG TATTAATTTC GCGGGATCGA
451 GATCGATCTC GATCCTCTAC GCCGGACGCA TCGTGGCCGG CATCACCGGC
501 GCCACAGGTG CGGTTGCTGG CGCCTATATC GCCGACATCA CCGATGGGGA
551 AGATCGGGCT CGCCACTTCG GGCTCATGAG CGCTTGTTTC GGCGTGGGTA
601 TGGTGGCAGG CCCCGTGGCC GGGGGACTGT TGGGCGCCAT CTCCTTGCAT
651 GCACCATTCC TTGCGGCGGC GGTGCTCAAC GGCCTCAACC TACTACTGGG
701 CTGCTTCCTA ATGCAGGAGT CGCATAAGGG AGAGCGTCGA GATCCCGGAC
751 ACCATCGAAT GGCGCAAAAC CTTTCGCGGT ATGGCATGAT AGCGCCCGGA
801 AGAGAGTCAA TTCAGGGTGG TGAATGTGAA ACCAGTAACG TTATACGATG
851 TCGCAGAGTA TGCCGGTGTC TCTTATCAGA CCGTTTCCCG CGTGGTGAAC
901 CAGGCCAGCC ACGTTTCTGC GAAAACGCGG GAAAAAGTGG AAGCGGCGAT
951 GGCGGAGCTG AATTACATTC CCAACCGCGT GGCACAACAA CTGGCGGGCA
1001 AACAGTCGTT GCTGATTGGC GTTGCCACCT CCAGTCTGGC CCTGCACGCG
1051 CCGTCGCAAA TTGTCGCGGC GATTAAATCT CGCGCCGATC AACTGGGTGC
1101 CAGCGTGGTG GTGTCGATGG TAGAACGAAG CGGCGTCGAA GCCTGTAAAG
1151 CGGCGGTGCA CAATCTTCTC GCGCAACGCG TCAGTGGGCT GATCATTAAC
1201 TATCCGCTGG ATGACCAGGA TGCCATTGCT GTGGAAGCTG CCTGCACTAA
1251 TGTTCCGGCG TTATTTCTTG ATGTCTCTGA CCAGACACCC ATCAACAGTA
1301 TTATTTTCTC CCATGAAGAC GGTACGCGAC TGGGCGTGGA GCATCTGGTC
1351 GCATTGGGTC ACCAGCAAAT CGCGCTGTTA GCGGGCCCAT TAAGTTCTGT
1401 CTCGGCGCGT CTGCGTCTGG CTGGCTGGCA TAAATATCTC ACTCGCAATC
1451 AAATTCAGCC GATAGCGGAA CGGGAAGGCG ACTGGAGTGC CATGTCCGGT
1501 TTTCAACAAA CCATGCAAAT GCTGAATGAG GGCATCGTTC CCACTGCGAT
1551 GCTGGTTGCC AACGATCAGA TGGCGCTGGG CGCAATGCGC GCCATTACCG
1601 AGTCCGGGCT GCGCGTTGGT GCGGACATCT CGGTAGTGGG ATACGACGAT
1651 ACCGAAGACA GCTCATGTTA TATCCCGCCG TTAACCACCA TCAAACAGGA
1701 TTTTCGCCTG CTGGGGCAAA CCAGCGTGGA CCGCTTGCTG CAACTCTCTC
1751 AGGGCCAGGC GGTGAAGGGC AATCAGCTGT TGCCCGTCTC ACTGGTGAAA
1801 AGAAAAACCA CCCTGGCGCC CAATACGCAA ACCGCCTCTC CCCGCGCGTT
1851 GGCCGATTCA TTAATGCAGC TGGCACGACA GGTTTCCCGA CTGGAAAGCG
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1901 GGCAGTGAGC GCAACGCAAT TAATGTAAGT TAGCTCACTC ATTAGGCACC
1951 GGGATCTCGA CCGATGCCCT TGAGAGCCTT CAACCCAGTC AGCTCCTTCC
2001 GGTGGGCGCG GGGCATGACT ATCGTCGCCG CACTTATGAC TGTCTTCTTT
2051 ATCATGCAAC TCGTAGGACA GGTGCCGGCA GCGCTCTGGG TCATTTTCGG
2101 CGAGGACCGC TTTCGCTGGA GCGCGACGAT GATCGGCCTG TCGCTTGCGG
2151 TATTCGGAAT CTTGCACGCC CTCGCTCAAG CCTTCGTCAC TGGTCCCGCC
2201 ACCAAACGTT TCGGCGAGAA GCAGGCCATT ATCGCCGGCA TGGCGGCCCC
2251 ACGGGTGCGC ATGATCGTGC TCCTGTCGTT GAGGACCCGG CTAGGCTGGC
2301 GGGGTTGCCT TACTGGTTAG CAGAATGAAT CACCGATACG CGAGCGAACG
2351 TGAAGCGACT GCTGCTGCAA AACGTCTGCG ACCTGAGCAA CAACATGAAT
2401 GGTCTTCGGT TTCCGTGTTT CGTAAAGTCT GGAAACGCGG AAGTCAGCGC
2451 CCTGCACCAT TATGTTCCGG ATCTGCATCG CAGGATGCTG CTGGCTACCC
2501 TGTGGAACAC CTACATCTGT ATTAACGAAG CGCTGGCATT GACCCTGAGT
2551 GATTTTTCTC TGGTCCCGCC GCATCCATAC CGCCAGTTGT TTACCCTCAC
2601 AACGTTCCAG TAACCGGGCA TGTTCATCAT CAGTAACCCG TATCGTGAGC
2651 ATCCTCTCTC GTTTCATCGG TATCATTACC CCCATGAACA GAAATCCCCC
2701 TTACACGGAG GCATCAGTGA CCAAACAGGA AAAAACCGCC CTTAACATGG
2751 CCCGCTTTAT CAGAAGCCAG ACATTAACGC TTCTGGAGAA ACTCAACGAG
2801 CTGGACGCGG ATGAACAGGC AGACATCTGT GAATCGCTTC ACGACCACGC
2851 TGATGAGCTT TACCGCAGCT GCCTCGCGCG TTTCGGTGAT GACGGTGAAA
2901 ACCTCTGACA CATGCAGCTC CCGGAGACGG TCACAGCTTG TCTGTAAGCG
2951 GATGCCGGGA GCAGACAAGC CCGTCAGGGC GCGTCAGCGG GTGTTGGCGG
3001 GTGTCGGGGC GCAGCCATGA CCCAGTCACG TAGCGATAGC GGAGTGTATA
3051 CTGGCTTAAC TATGCGGCAT CAGAGCAGAT TGTACTGAGA GTGCACCATA
3101 TATGCGGTGT GAAATACCGC ACAGATGCGT AAGGAGAAAA TACCGCATCA
3151 GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC GGTCGTTCGG
3201 CTGCGGCGAG CGGTATCAGC TCACTCAAAG GCGGTAATAC GGTTATCCAC
3251 AGAATCAGGG GATAACGCAG GAAAGAACAT GTGAGCAAAA GGCCAGCAAA
3301 AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT CCATAGGCTC
3351 CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC AGAGGTGGCG
3401 AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT GGAAGCTCCC
3451 TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA CCTGTCCGCC
3501 TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC GCTGTAGGTA
3551 TCTCAGTTCG GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT GTGCACGAAC
3601 CCCCCGTTCA GCCCGACCGC TGCGCCTTAT CCGGTAACTA TCGTCTTGAG
3651 TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG CCACTGGTAA
3701 CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG TTCTTGAAGT
3751 GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG TATCTGCGCT
3801 CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT CTTGATCCGG
3851 CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC AAGCAGCAGA
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3901 TTACGCGCAG AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT CTTTTCTACG
3951 GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA TTTTGGTCAT
4001 GAACAATAAA ACTGTCTGCT TACATAAACA GTAATACAAG GGGTGTTATG
4051 AGCCATATTC AACGGGAAAC GTCTTGCTCT AGGCCGCGAT TAAATTCCAA
4101 CATGGATGCT GATTTATATG GGTATAAATG GGCTCGCGAT AATGTCGGGC
4151 AATCAGGTGC GACAATCTAT CGATTGTATG GGAAGCCCGA TGCGCCAGAG
4201 TTGTTTCTGA AACATGGCAA AGGTAGCGTT GCCAATGATG TTACAGATGA
4251 GATGGTCAGA CTAAACTGGC TGACGGAATT TATGCCTCTT CCGACCATCA
4301 AGCATTTTAT CCGTACTCCT GATGATGCAT GGTTACTCAC CACTGCGATC
4351 CCCGGGAAAA CAGCATTCCA GGTATTAGAA GAATATCCTG ATTCAGGTGA
4401 AAATATTGTT GATGCGCTGG CAGTGTTCCT GCGCCGGTTG CATTCGATTC
4451 CTGTTTGTAA TTGTCCTTTT AACAGCGATC GCGTATTTCG TCTCGCTCAG
4501 GCGCAATCAC GAATGAATAA CGGTTTGGTT GATGCGAGTG ATTTTGATGA
4551 CGAGCGTAAT GGCTGGCCTG TTGAACAAGT CTGGAAAGAA ATGCATAAAC
4601 TTTTGCCATT CTCACCGGAT TCAGTCGTCA CTCATGGTGA TTTCTCACTT
4651 GATAACCTTA TTTTTGACGA GGGGAAATTA ATAGGTTGTA TTGATGTTGG
4701 ACGAGTCGGA ATCGCAGACC GATACCAGGA TCTTGCCATC CTATGGAACT
4751 GCCTCGGTGA GTTTTCTCCT TCATTACAGA AACGGCTTTT TCAAAAATAT
4801 GGTATTGATA ATCCTGATAT GAATAAATTG CAGTTTCATT TGATGCTCGA
4851 TGAGTTTTTC TAAGAATTAA TTCATGAGCG GATACATATT TGAATGTATT
4901 TAGAAAAATA AACAAATAGG GGTTCCGCGC ACATTTCCCC GAAAAGTGCC
4951 ACCTGAAATT GTAAACGTTA ATATTTTGTT AAAATTCGCG TTAAATTTTT
5001 GTTAAATCAG CTCATTTTTT AACCAATAGG CCGAAATCGG CAAAATCCCT
5051 TATAAATCAA AAGAATAGAC CGAGATAGGG TTGAGTGTTG TTCCAGTTTG
5101 GAACAAGAGT CCACTATTAA AGAACGTGGA CTCCAACGTC AAAGGGCGAA
5151 AAACCGTCTA TCAGGGCGAT GGCCCACTAC GTGAACCATC ACCCTAATCA
5201 AGTTTTTTGG GGTCGAGGTG CCGTAAAGCA CTAAATCGGA ACCCTAAAGG
5251 GAGCCCCCGA TTTAGAGCTT GACGGGGAAA GCCGGCGAAC GTGGCGAGAA
5301 AGGAAGGGAA GAAAGCGAAA GGAGCGGGCG CTAGGGCGCT GCAAGTGTA
5351 GCGGTCACGC TGCGCGTAAC CACCACACCC GCCGCGCTTA ATGCGCCGCT
5401 ACAGGGCGCG TCCCATTCGC CA
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Figure A.4 Plasmid map of pET-30a (+)_P450cam.
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Figure A.5 Nucleotide sequence of plasmid containing vector pET-30a(+) and WT
cytochrome P450cam gene. (152+1426+5072=6670bp)
1 ATCCGGATAT AGTTCCTCCT TTCAGCAAAA AACCCCTCAA GACCCGTTTA
51 GAGGCCCCAA GGGGTTATGC TAGTTATTGC TCAGCGGTGG CAGCAGCCAA
101 CTCAGCTTCC TTTCGGGCTT TGTTAGCAGC CGGATCTCAG TGGTGGTGGT
151 GGTGGTGCTC GAGTGCGGCC GCAAGCTTTG GATAGCGGTG GTAGGTGATG
201 GGGAATTACC GTCGCATCCC CCACCAACCG GATATTGCCT TCCCAGCCGC
251 TGGCGCGCAG GCCGAAGGCG ACCTCAACGC CAGCCAGTCC GGTACCGACG
301 ATGACCACGT TGTCGTTTGC GTTCACTTAG CACGCACTCC CATGTGTTTA
351 TACCGCTTTG GTAGTCGCCG GATCCCAGAC CAGAGGGAGT GCCTGCACGC
401 CGCTGACGAT GCCGCTCTTG TGCTGAATCT GGGCACCCGG GGCAATGGAG
451 AAGTCAGGAA TCCTGGTCAG CCATTCCTTG AGGGTGACGA TGATTTCCCG
501 GCGGGCCAGG TGCTGGCCAA GGCACAGATG GCTGCCGTGG CCAAAGGTGG
551 TGTGTGAAAC CTTTTGGCGA CTGAAGTCGA CGTGCATCGG GCAGGCGTTT
601 TCGCGCTCAT CCAGGCCAGA CAGCATCTGC GGTAGCAGGA TCTGGTCACC
651 TTTCTTCAGT TGCACGCCAT GAAACTCGTA ATCGGAGGTG AGGATGCGGC
701 CATCGGCAAC CAGCGAGAAG CGCCGGAGTA GTTCCTCGCA AGCGGCTGGA
751 ATACGCTCGG GACGCTCGAT CAGCTCCTGG CGATGCTCCG GGCTTTTGGC
801 CAGGAACTCC ATGCTGAAGC TGAGGAAATT GACCACCGTA TCCAGGCCGC
851 CGACCAGTAA CAGGCCACAC ATCCTCTTGG CTTCGTCACT GGTGATCGGT
901 CGCCCATTGA CCTGGCCGTT GGCAACGATG CTGATAGCGT CGGTTCCCGG
951 CTTCTGCCTG CGTTGCTCGA TGATCGGTAT CAGATAGTC GTAGAGCGCCT
1001 CCTTGGCCTC TGCGAAGGTC ATGCTGCCAT CCGGACGGGT CATCTGATCC
1051 GTTAGGTATT TCAAGTGCGG GATATCTTCT TCCGGTAGAC CTGCGAGCAG
1101 CATGAAGATG CGTATCGGGA AGGGTTCGGC GTAGTCCTCG GTGAAGTTGC
1151 ACTGTCCTTG CGGGCGCAGG CTCTCGATCA GCGAGCAGGC CAGCTCCTGG
1201 ATCCGGTTCT CCAGCTTATC CACCACCGGC ATGCCAACCA CTTGGTTGGC
1251 CAGCGCACGA AACTGGCGCT GCTCGGGCGG ATCCATCGAG GTGGGAATGA
1301 AGTCGTAGGC TTCGCCGGCT TCACGAGGGA TGAACGGGCA CTCGCTGGAA
1351 AAGTGGCGGT AATCTTCATA GGCCTCACGG ATCAGTTGGC CGCGAGTGGC
1401 GATCCAGTGT CCGCCGTTGC AGCGAGTCCA CACCAGATCC GGTACGTTTG
1451 ATTCTTGCAG AACTGCCCAG GCCTCCTGCA CGCCGGCAGA CAGATTCGAC
1501 GGATTGTACA TGTCGAAGTC GAATACCAGG TGCTCTGGCA CATGGGGTGG
1551 CAGAGGGGCA AGATTGGCGT TGCTTTGTAT GGTTTCAGTC GTCATATGTA
1601 TATCTCCTTC TTAAAGTTAA ACAAAATTAT TTCTAGAGGG GAATTGTTAT
1651 CCGCTCACAA TTCCCCTATA GTGAGTCGTA TTAATTTCGC GGGATCGAGA
1701 TCGATCTCGA TCCTCTACGC CGGACGCATC GTGGCCGGCA TCACCGGCGC
1751 CACAGGTGCG GTTGCTGGCG CCTATATCGC CGACATCACC GATGGGGAAG
1801 ATCGGGCTCG CCACTTCGGG CTCATGAGCG CTTGTTTCGG CGTGGGTATG
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1851 GTGGCAGGCC CCGTGGCCGG GGGACTGTTG GGCGCCATCT CCTTGCATGC
1901 ACCATTCCTT GCGGCGGCGG TGCTCAACGG CCTCAACCTA CTACTGGGCT
1951 GCTTCCTAAT GCAGGAGTCG CATAAGGGAG AGCGTCGAGA TCCCGGACAC
2001 CATCGAATGG CGCAAAACCT TTCGCGGTAT GGCATGATAG CGCCCGGAAG
2051 AGAGTCAATT CAGGGTGGTG AATGTGAAAC CAGTAACGTT ATACGATGTC
2101 GCAGAGTATG CCGGTGTCTC TTATCAGACC GTTTCCCGCG TGGTGAACCA
2151 GGCCAGCCAC GTTTCTGCGA AAACGCGGGA AAAAGTGGAA GCGGCGATGG
2201 CGGAGCTGAA TTACATTCCC AACCGCGTGG CACAACAACT GGCGGGCAAA
2251 CAGTCGTTGC TGATTGGCGT TGCCACCTCC AGTCTGGCCC TGCACGCGCC
2301 GTCGCAAATT GTCGCGGCGA TTAAATCTCG CGCCGATCAA CTGGGTGCCA
2351 GCGTGGTGGT GTCGATGGTA GAACGAAGCG GCGTCGAAGC CTGTAAAGCG
2401 GCGGTGCACA ATCTTCTCGC GCAACGCGTC AGTGGGCTGA TCATTAACTA
2451 TCCGCTGGAT GACCAGGATG CCATTGCTGT GGAAGCTGCC TGCACTAATG
2501 TTCCGGCGTT ATTTCTTGAT GTCTCTGACC AGACACCCAT CAACAGTATT
2551 ATTTTCTCCC ATGAAGACGG TACGCGACTG GGCGTGGAGC ATCTGGTCGC
2601 ATTGGGTCAC CAGCAAATCG CGCTGTTAGC GGGCCCATTA AGTTCTGTCT
2651 CGGCGCGTCT GCGTCTGGCT GGCTGGCATA AATATCTCAC TCGCAATCAA
2701 ATTCAGCCGA TAGCGGAACG GGAAGGCGAC TGGAGTGCCA TGTCCGGTTT
2751 TCAACAAACC ATGCAAATGC TGAATGAGGG CATCGTTCCC ACTGCGATGC
2801 TGGTTGCCAA CGATCAGATG GCGCTGGGCG CAATGCGCGC CATTACCGAG
2851 TCCGGGCTGC GCGTTGGTGC GGACATCTCG GTAGTGGGAT ACGACGATAC
2901 CGAAGACAGC TCATGTTATA TCCCGCCGTT AACCACCATC AAACAGGATT
2951 TTCGCCTGCT GGGGCAAACC AGCGTGGACC GCTTGCTGCA ACTCTCTCAG
3001 GGCCAGGCGG TGAAGGGCAA TCAGCTGTTG CCCGTCTCAC TGGTGAAAAG
3051 AAAAACCACC CTGGCGCCCA ATACGCAAAC CGCCTCTCCC CGCGCGTTGG
3101 CCGATTCATT AATGCAGCTG GCACGACAGG TTTCCCGACT GGAAAGCGGG
3151 CAGTGAGCGC AACGCAATTA ATGTAAGTTA GCTCACTCAT TAGGCACCGG
3201 GATCTCGACC GATGCCCTTG AGAGCCTTCA ACCCAGTCAG CTCCTTCCGG
3251 TGGGCGCGGG GCATGACTAT CGTCGCCGCA CTTATGACTG TCTTCTTTAT
3301 CATGCAACTC GTAGGACAGG TGCCGGCAGC GCTCTGGGTC ATTTTCGGCG
3351 AGGACCGCTT TCGCTGGAGC GCGACGATGA TCGGCCTGTC GCTTGCGGTA
3401 TTCGGAATCT TGCACGCCCT CGCTCAAGCC TTCGTCACTG GTCCCGCCAC
3451 CAAACGTTTC GGCGAGAAGC AGGCCATTAT CGCCGGCATG GCGGCCCCAC
3501 GGGTGCGCAT GATCGTGCTC CTGTCGTTGA GGACCCGGCT AGGCTGGCGG
3551 GGTTGCCTTA CTGGTTAGCA GAATGAATCA CCGATACGCG AGCGAACGTG
3601 AAGCGACTGC TGCTGCAAAA CGTCTGCGAC CTGAGCAACA ACATGAATGG
3651 TCTTCGGTTT CCGTGTTTCG TAAAGTCTGG AAACGCGGAA GTCAGCGCCC
3701 TGCACCATTA TGTTCCGGAT CTGCATCGCA GGATGCTGCT GGCTACCCTG
3751 TGGAACACCT ACATCTGTAT TAACGAAGCG CTGGCATTGA CCCTGAGTGA
3801 TTTTTCTCTG GTCCCGCCGC ATCCATACCG CCAGTTGTTT ACCCTCACAA
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3851 CGTTCCAGTA ACCGGGCATG TTCATCATCA GTAACCCGTA TCGTGAGCAT
3901 CCTCTCTCGT TTCATCGGTA TCATTACCCC CATGAACAGA AATCCCCCTT
3951 ACACGGAGGC ATCAGTGACC AAACAGGAAA AAACCGCCCT TAACATGGCC
4001 CGCTTTATCA GAAGCCAGAC ATTAACGCTT CTGGAGAAAC TCAACGAGCT
4051 GGACGCGGAT GAACAGGCAG ACATCTGTGA ATCGCTTCAC GACCACGCTG
4101 ATGAGCTTTA CCGCAGCTGC CTCGCGCGTT TCGGTGATGA CGGTGAAAAC
4151 CTCTGACACA TGCAGCTCCC GGAGACGGTC ACAGCTTGTC TGTAAGCGGA
4201 TGCCGGGAGC AGACAAGCCC GTCAGGGCGC GTCAGCGGGT GTTGGCGGGT
4251 GTCGGGGCGC AGCCATGACC CAGTCACGTA GCGATAGCGG AGTGTATACT
4301 GGCTTAACTA TGCGGCATCA GAGCAGATTG TACTGAGAGT GCACCATATA
4351 TGCGGTGTGA AATACCGCAC AGATGCGTAA GGAGAAAATA CCGCATCAGG
4401 CGCTCTTCCG CTTCCTCGCT CACTGACTCG CTGCGCTCGG TCGTTCGGCT
4451 GCGGCGAGCG GTATCAGCTC ACTCAAAGGC GGTAATACGG TTATCCACAG
4501 AATCAGGGGA TAACGCAGGA AAGAACATGT GAGCAAAAGG CCAGCAAAAG
4551 GCCAGGAACC GTAAAAAGGC CGCGTTGCTG GCGTTTTTCC ATAGGCTCCG
4601 CCCCCCTGAC GAGCATCACA AAAATCGACG CTCAAGTCAG AGGTGGCGAA
4651 ACCCGACAGG ACTATAAAGA TACCAGGCGT TTCCCCCTGG AAGCTCCCTC
4701 GTGCGCTCTC CTGTTCCGAC CCTGCCGCTT ACCGGATACC TGTCCGCCTT
4751 TCTCCCTTCG GGAAGCGTGG CGCTTTCTCA TAGCTCACGC TGTAGGTATC
4801 TCAGTTCGGT GTAGGTCGTT CGCTCCAAGC TGGGCTGTGT GCACGAACCC
4851 CCCGTTCAGC CCGACCGCTG CGCCTTATCC GGTAACTATC GTCTTGAGTC
4901 CAACCCGGTA AGACACGACT TATCGCCACT GGCAGCAGCC ACTGGTAACA
4951 GGATTAGCAG AGCGAGGTAT GTAGGCGGTG CTACAGAGTT CTTGAAGTGG
5001 TGGCCTAACT ACGGCTACAC TAGAAGGACA GTATTTGGTA TCTGCGCTCT
5051 GCTGAAGCCA GTTACCTTCG GAAAAAGAGT TGGTAGCTCT TGATCCGGCA
5101 AACAAACCAC CGCTGGTAGC GGTGGTTTTT TTGTTTGCAA GCAGCAGATT
5151 ACGCGCAGAA AAAAAGGATC TCAAGAAGAT CCTTTGATCT TTTCTACGGG
5201 GTCTGACGCT CAGTGGAACG AAAACTCACG TTAAGGGATT TTGGTCATGA
5251 ACAATAAAAC TGTCTGCTTA CATAAACAGT AATACAAGGG GTGTTATGAG
5301 CCATATTCAA CGGGAAACGT CTTGCTCTAG GCCGCGATTA AATTCCAACA
5351 TGGATGCTGA TTTATATGGG TATAAATGGG CTCGCGATAA TGTCGGGCAA
5401 TCAGGTGCGA CAATCTATCG ATTGTATGGG AAGCCCGATG CGCCAGAGTT
5451 GTTTCTGAAA CATGGCAAAG GTAGCGTTGC CAATGATGTT ACAGATGAGA
5501 TGGTCAGACT AAACTGGCTG ACGGAATTTA TGCCTCTTCC GACCATCAAG
5551 CATTTTATCC GTACTCCTGA TGATGCATGG TTACTCACCA CTGCGATCCC
5601 CGGGAAAACA GCATTCCAGG TATTAGAAGA ATATCCTGAT TCAGGTGAAA
5651 ATATTGTTGA TGCGCTGGCA GTGTTCCTGC GCCGGTTGCA TTCGATTCCT
5701 GTTTGTAATT GTCCTTTTAA CAGCGATCGC GTATTTCGTC TCGCTCAGGC
5751 GCAATCACGA ATGAATAACG GTTTGGTTGA TGCGAGTGAT TTTGATGACG
5801 AGCGTAATGG CTGGCCTGTT GAACAAGTCT GGAAAGAAAT GCATAAACTT
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5851 TTGCCATTCT CACCGGATTC AGTCGTCACT CATGGTGATT TCTCACTTGA
5901 TAACCTTATT TTTGACGAGG GGAAATTAAT AGGTTGTATT GATGTTGGAC
5951 GAGTCGGAAT CGCAGACCGA TACCAGGATC TTGCCATCCT ATGGAACTGC
6001 CTCGGTGAGT TTTCTCCTTC ATTACAGAAA CGGCTTTTTC AAAAATATGG
6051 TATTGATAAT CCTGATATGA ATAAATTGCA GTTTCATTTG ATGCTCGATG
6101 AGTTTTTCTA AGAATTAATT CATGAGCGGA TACATATTTG AATGTATTTA
6151 GAAAAATAAA CAAATAGGGG TTCCGCGCAC ATTTCCCCGA AAAGTGCCAC
6201 CTGAAATTGT AAACGTTAAT ATTTTGTTAA AATTCGCGTT AAATTTTTGT
6251 TAAATCAGCT CATTTTTTAA CCAATAGGCC GAAATCGGCA AAATCCCTTA
6301 TAAATCAAAA GAATAGACCG AGATAGGGTT GAGTGTTGTT CCAGTTTGGA
6351 ACAAGAGTCC ACTATTAAAG AACGTGGACT CCAACGTCAA AGGGCGAAAA
6401 ACCGTCTATC AGGGCGATGG CCCACTACGT GAACCATCAC CCTAATCAAG
6451 TTTTTTGGGG TCGAGGTGCC GTAAAGCACT AAATCGGAAC CCTAAAGGGA
6501 GCCCCCGATT TAGAGCTTGA CGGGGAAAGC CGGCGAACGT GGCGAGAAAG
6551 GAAGGGAAGA AAGCGAAAGG AGCGGGCGCT AGGGCGCTGG CAAGTGTAGC
6601 GGTCACGCTG CGCGTAACCA CCACACCCGC CGCGCTTAAT GCGCCGCTAC
6651 AGGGCGCGTC CCATTCGCCA
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APPENDIX B
Sequences of Sperm Whale Myoglobin and pET-30a (+) Vector
General information
The sperm whale myoglobin includes 154 amino acids.
Figure B.1 lists the amino acid sequence of full-length, wild-type sperm whale
myoglobin.
Figure B.1 lists the nucleotide sequence of the synthesized sperm whale myoglobin gene
as designed from the amio acid sequence including the ribosome binding site. (Springer,
B. et al, Proc Natl Acad Sci USA, 1987, 84, 8961-8965)
Figure B.3 displays a map of plasmid pET-30a (+)_Mb, which is the pET-30a (+) vector
with the sperm whale myoglobin gene cloned in.
Figure B.4 lists the nucleotide sequence of plasmid pET-30a (+)_Mb containing vector
pET-30a(+) and wild-type sperm whale myoglobin gene cloned into NdeI (5’-end,
nucleotide position 713 in the pET-30a (+) vector sequence) and KpNI (3’-end,
nucleotide position 238 in the pET-30a (+) vector sequence). The numbering is
correspondent to that of Figure B.4.
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Figure B.1 Amino acid sequence of full-length of sperm whale myoglobin (154aa).
1 MVLSEGEWQL VLHVWAKVEA DVAGHGQDIL IRLFKSHPET LEKFDRFKHL
51 KTEAEMKASE DLKKHGVTVL TALGAILKKK GHHEAELKPL AQSHATKHKI
101 PIKYLEFISE AIIHVLHSRH PGNFGADAQG AMNKALELFR KDIAAKYKEL
151 GYQG

Figure B.2 Nucleotide sequence of full-length sperm whale myoglobin (507bp).
1 CTGCAGATAA CTAACTAAAG GAGAACAACA ACAATGGTTC TGTCTGAAGG
51 TGAATGGCAG CTGGTTCTGC ATGTTTGGGC TAAAGTTGAA GCTGACGTCG
101 CTGGTCATGG TCAGGACATC TTGATTCGAC TGTTCAAATC TCATCCGGAA
151 ACTCTGGAAA AATTCGATCG TTTCAAACAT CTGAAAACTG AAGCTGAAAT
201 GAAAGCTTCT GAAGATCTGA AAAAACATGG TGTTACCGTG TTAACTGCCC
251 TAGGTGCTAT CCTTAAGAAA AAAGGGCATC ATGAAGCTGA GCTCAAACCG
301 CTTGCGCAAT CGCATGCTAC TAAACATAAG ATCCCGATCA AATACCTGGA
351 ATTCATCTCT GAAGCGATCA TCCATGTTCT GCATTCTAGA CATCCAGGTA
401 ACTTCGGTGC TGACGCTCAG GGTGCTATGA ACAAAGCTCT CGAGCTGTTC 451
CGTAAAGATA TCGCTGCTAA GTACAAAGAA CTGGGTTACC AGGGTTAATG
501 AGGTACC
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Figure B.3 Plasmid map of pET-30a (+)_Mb.
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Figure B.4 Nucleotide sequence of plasmid containing vector pET-30a (+) and sperm
whale myglobin gene (5782bp).
1 ATCCGGATAT AGTTCCTCCT TTCAGCAAAA AACCCCTCAA GACCCGTTTA
51 GAGGCCCCAA GGGGTTATGC TAGTTATTGC TCAGCGGTGG CAGCAGCCAA
101 CTCAGCTTCC TTTCGGGCTT TGTTAGCAGC CGGATCTCAG TGGTGGTGGT
151 GGTGGTGCTC GAGTGCGGCC GCAAGCTTGT CGACGGAGCT CGAATTCGGA
201 TCCGATATCA GCCATGGCCT TGTCGTCGTC GTCGGTACCT CATTA ACCCT
251 GGTAACCCAG TTCTTTGTAC TTAGCAGCGA TATCTTTACG GAACAGCTCG
301 AGAGCTTTGT TCATAGCACC CTGAGCGTCA GCACCGAAGT CACCTGGATG
351 TCTAGAATGC AGAACATGGA TGATCGCTTC AGAGATGAAT TCCAGGTATT
401 TGATCGGGAT CTTATGTTTA GTAGCATGCG ATTGCGCAAG CGGTTTGAGC
451 TCAGCTTCAT GATGCCCTTT TTTCTTAAGG ATAGCACCTA GGGCAGTTAA
501 CACGGTAACA CCATGTTTTT TCAGATCTTC AGAAGCTTTC ATTTCAGCTT
551 CAGTTTTCAG ATGTTTGAAA CGATCGAATT TTTCCAGAGT TTCCGGATGA
601 GATTTGAACA GTCGAATCAA GATGTCCTGA CCATGACCAG CGACGTCAGC
651 TTCAACTTTA GCCCAAACAT GCAGAACCAG CTGCCATTCA CCTTCAGACA
701 GAACCATATG TATATCTCCT TCTTAAAGTT AAACAAAATT ATTTCTAGAG
751 GGGAATTGTT ATCCGCTCAC AATTCCCCTA TAGTGAGTCG TATTAATTTC
801 GCGGGATCGA GATCGATCTC GATCCTCTAC GCCGGACGCA TCGTGGCCGG
851 CATCACCGGC GCCACAGGTG CGGTTGCTGG CGCCTATATC GCCGACATCA
901 CCGATGGGGA AGATCGGGCT CGCCACTTCG GGCTCATGAG CGCTTGTTTC
951 GGCGTGGGTA TGGTGGCAGG CCCCGTGGCC GGGGGACTGT TGGGCGCCAT
1001 CTCCTTGCAT GCACCATTCC TTGCGGCGGC GGTGCTCAAC GGCCTCAACC
1051 TACTACTGGG CTGCTTCCTA ATGCAGGAGT CGCATAAGGG AGAGCGTCGA
1101 GATCCCGGAC ACCATCGAAT GGCGCAAAAC CTTTCGCGGT ATGGCATGAT
1151 AGCGCCCGGA AGAGAGTCAA TTCAGGGTGG TGAATGTGAA ACCAGTAACG
1201 TTATACGATG TCGCAGAGTA TGCCGGTGTC TCTTATCAGA CCGTTTCCCG
1251CGTGGTGAAC CAGGCCAGCC ACGTTTCTGC GAAAACGCGG GAAAAAGTGG
1301 AAGCGGCGAT GGCGGAGCTG AATTACATTC CCAACCGCGT GGCACAACAA
1351 CTGGCGGGCA AACAGTCGTT GCTGATTGGC GTTGCCACCT CCAGTCTGGC
1401 CCTGCACGCG CCGTCGCAAA TTGTCGCGGC GATTAAATCT CGCGCCGATC
1451 AACTGGGTGC CAGCGTGGTG GTGTCGATGG TAGAACGAAG CGGCGTCGAA
1501 GCCTGTAAAG CGGCGGTGCA CAATCTTCTC GCGCAACGCG TCAGTGGGCT
1551 GATCATTAAC TATCCGCTGG ATGACCAGGA TGCCATTGCT GTGGAAGCTG
1601 CCTGCACTAA TGTTCCGGCG TTATTTCTTG ATGTCTCTGA CCAGACACCC
1651 ATCAACAGTA TTATTTTCTC CCATGAAGAC GGTACGCGAC TGGGCGTGGA
1701 GCATCTGGTC GCATTGGGTC ACCAGCAAAT CGCGCTGTTA GCGGGCCCAT
1751 TAAGTTCTGT CTCGGCGCGT CTGCGTCTGG CTGGCTGGCA TAAATATCTC
1801 ACTCGCAATC AAATTCAGCC GATAGCGGAA CGGGAAGGCG ACTGGAGTGC

168

1851 CATGTCCGGT TTTCAACAAA CCATGCAAAT GCTGAATGAG GGCATCGTTC
1901 CCACTGCGAT GCTGGTTGCC AACGATCAGA TGGCGCTGGG CGCAATGCGC
1951 GCCATTACCG AGTCCGGGCT GCGCGTTGGT GCGGACATCT CGGTAGTGGG
2001 ATACGACGAT ACCGAAGACA GCTCATGTTA TATCCCGCCG TTAACCACCA
2051 TCAAACAGGA TTTTCGCCTG CTGGGGCAAA CCAGCGTGGA CCGCTTGCTG
2101 CAACTCTCTC AGGGCCAGGC GGTGAAGGGC AATCAGCTGT TGCCCGTCTC
2151 ACTGGTGAAA AGAAAAACCA CCCTGGCGCC CAATACGCAA ACCGCCTCTC
2201 CCCGCGCGTT GGCCGATTCA TTAATGCAGC TGGCACGACA GGTTTCCCGA
2251 CTGGAAAGCG GGCAGTGAGC GCAACGCAAT TAATGTAAGT TAGCTCACTC
2301 ATTAGGCACC GGGATCTCGA CCGATGCCCT TGAGAGCCTT CAACCCAGTC
2351 AGCTCCTTCC GGTGGGCGCG GGGCATGACT ATCGTCGCCG CACTTATGAC
2401 TGTCTTCTTT ATCATGCAAC TCGTAGGACA GGTGCCGGCA GCGCTCTGGG
2451 TCATTTTCGG CGAGGACCGC TTTCGCTGGA GCGCGACGAT GATCGGCCTG
2501 TCGCTTGCGG TATTCGGAAT CTTGCACGCC CTCGCTCAAG CCTTCGTCAC
2551 TGGTCCCGCC ACCAAACGTT TCGGCGAGAA GCAGGCCATT ATCGCCGGCA
2601 TGGCGGCCCC ACGGGTGCGC ATGATCGTGC TCCTGTCGTT GAGGACCCGG
2651 CTAGGCTGGC GGGGTTGCCT TACTGGTTAG CAGAATGAAT CACCGATACG
2701 CGAGCGAACG TGAAGCGACT GCTGCTGCAA AACGTCTGCG ACCTGAGCAA
2751 CAACATGAAT GGTCTTCGGT TTCCGTGTTT CGTAAAGTCT GGAAACGCGG
2801 AAGTCAGCGC CCTGCACCAT TATGTTCCGG ATCTGCATCG CAGGATGCTG
2851 CTGGCTACCC TGTGGAACAC CTACATCTGT ATTAACGAAG CGCTGGCATT
2901 GACCCTGAGT GATTTTTCTC TGGTCCCGCC GCATCCATAC CGCCAGTTGT
2951 TTACCCTCAC AACGTTCCAG TAACCGGGCA TGTTCATCAT CAGTAACCCG
3001 TATCGTGAGC ATCCTCTCTC GTTTCATCGG TATCATTACC CCCATGAACA
3051 GAAATCCCCC TTACACGGAG GCATCAGTGA CCAAACAGGA AAAAACCGCC
3101 CTTAACATGG CCCGCTTTAT CAGAAGCCAG ACATTAACGC TTCTGGAGAA
3151 ACTCAACGAG CTGGACGCGG ATGAACAGGC AGACATCTGT GAATCGCTTC
3201 ACGACCACGC TGATGAGCTT TACCGCAGCT GCCTCGCGCG TTTCGGTGAT
3251 GACGGTGAAA ACCTCTGACA CATGCAGCTC CCGGAGACGG TCACAGCTTG
3301 TCTGTAAGCG GATGCCGGGA GCAGACAAGC CCGTCAGGGC GCGTCAGCGG
3351 GTGTTGGCGG GTGTCGGGGC GCAGCCATGA CCCAGTCACG TAGCGATAGC
3401 GGAGTGTATA CTGGCTTAAC TATGCGGCAT CAGAGCAGAT TGTACTGAGA
3451 GTGCACCATA TATGCGGTGT GAAATACCGC ACAGATGCGT AAGGAGAAAA
3501 TACCGCATCA GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC
3551 GGTCGTTCGG CTGCGGCGAG CGGTATCAGC TCACTCAAAG GCGGTAATAC
3601 GGTTATCCAC AGAATCAGGGGATAACGCAG GAAAGAACATGTGAGCAAAA
3651 GGCCAGCAAA AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT
3701 CCATAGGCTC CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC
3751 AGAGGTGGCG AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT
3801 GGAAGCTCCC TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA
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3851 CCTGTCCGCC TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC
3901 GCTGTAGGTA TCTCAGTTCG GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT
3951 GTGCACGAAC CCCCCGTTCA GCCCGACCGC TGCGCCTTAT CCGGTAACTA
4001 TCGTCTTGAG TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG
4051 CCACTGGTAA CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG
4101 TTCTTGAAGT GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG
4151 TATCTGCGCT CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT
4201 CTTGATCCGG CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC
4251 AAGCAGCAGA TTACGCGCAG AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT
4301 CTTTTCTACG GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA
4351 TTTTGGTCAT GAACAATAAA ACTGTCTGCT TACATAAACA GTAATACAAG
4401 GGGTGTTATG AGCCATATTC AACGGGAAAC GTCTTGCTCT AGGCCGCGAT
4451 TAAATTCCAA CATGGATGCT GATTTATATG GGTATAAATG GGCTCGCGAT
4501 AATGTCGGGC AATCAGGTGC GACAATCTAT CGATTGTATG GGAAGCCCGA
4551 TGCGCCAGAG TTGTTTCTGA AACATGGCAA AGGTAGCGTT GCCAATGATG
4601 TTACAGATGA GATGGTCAGA CTAAACTGGC TGACGGAATT TATGCCTCTT
4651 CCGACCATCA AGCATTTTAT CCGTACTCCT GATGATGCAT GGTTACTCAC
4701 CACTGCGATC CCCGGGAAAA CAGCATTCCA GGTATTAGAA GAATATCCTG
4751 ATTCAGGTGA AAATATTGTT GATGCGCTGG CAGTGTTCCT GCGCCGGTTG
4801 CATTCGATTC CTGTTTGTAA TTGTCCTTTT AACAGCGATC GCGTATTTCG
4851 TCTCGCTCAG GCGCAATCAC GAATGAATAA CGGTTTGGTT GATGCGAGTG
4901 ATTTTGATGA CGAGCGTAAT GGCTGGCCTG TTGAACAAGT CTGGAAAGAA
4951 ATGCATAAAC TTTTGCCATT CTCACCGGAT TCAGTCGTCA CTCATGGTGA
5001 TTTCTCACTT GATAACCTTA TTTTTGACGA GGGGAAATTA ATAGGTTGTA
5051 TTGATGTTGG ACGAGTCGGA ATCGCAGACC GATACCAGGA TCTTGCCATC
5101 CTATGGAACT GCCTCGGTGA GTTTTCTCCT TCATTACAGA AACGGCTTTT
5151 TCAAAAATAT GGTATTGATA ATCCTGATAT GAATAAATTG CAGTTTCATT
5201 TGATGCTCGA TGAGTTTTTC TAAGAATTAA TTCATGAGCG GATACATATT
5251 TGAATGTATT TAGAAAAATA AACAAATAGG GGTTCCGCGC ACATTTCCCC
5301 GAAAAGTGCC ACCTGAAATT GTAAACGTTA ATATTTTGTT AAAATTCGCG
5351 TTAAATTTTT GTTAAATCAG CTCATTTTTT AACCAATAGG CCGAAATCGG
5401 CAAAATCCCT TATAAATCAA AAGAATAGAC CGAGATAGGG TTGAGTGTTG
5451 TTCCAGTTTG GAACAAGAGT CCACTATTAA AGAACGTGGA CTCCAACGTC
5501 AAAGGGCGAA AAACCGTCTA TCAGGGCGAT GGCCCACTAC GTGAACCATC
5551 ACCCTAATCA AGTTTTTTGG GGTCGAGGTG CCGTAAAGCA CTAAATCGGA
5601 ACCCTAAAGG GAGCCCCCGA TTTAGAGCTT GACGGGGAAA GCCGGCGAAC
5651GTGGCGAGAAAGGAAGGGAAGAAAGCGAAA GGAGCGGGCG CTAGGGCGCT
5701 GCAAGTGTA GCGGTCACGC TGCGCGTAAC CACCACACCC GCCGCGCTTA
5751 ATGCGCCGCT ACAGGGCGCG TCCCATTCGC CA
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APPENDIX C

General information
Table C1 and C2 list all the primers designed for wild type cytochrome P450cam and
sperm whale myoglobin and their mutants in this dissertation study.
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